Document:

Exhibit 4.6

 

LabStyle
Innovations Corp.

 

2012
Equity Incentive Plan

 

Adopted
on January 23, 2012 

 

1.                 
Purposes.

 

(a)              
Eligible Recipients. The persons eligible to receive awards hereunder are the Employees, Directors and Consultants of
the Company and its Affiliates.

 

(b)              
Available Awards. The purpose of the Plan is to provide a means by which eligible recipients of Option Awards may be
given an opportunity to benefit from increases in value of the Common Stock through the granting of: (i) Incentive Stock Options
and (ii) Nonstatutory Stock Options.

 

(c)               
General Purpose. The Company, by means of the Plan, seeks to retain the services of the group of persons eligible to
receive Option Awards, to secure and retain the services of new members of this group and to provide incentives for such persons
to exert maximum efforts for the success of the Company and its Affiliates.

 

2.                 
Definitions. The following capitalized terms have the following meanings.
Other capitalized terms are defined elsewhere herein.

 

(a)              
“Affiliate” means (i) any person or entity that directly or indirectly controls, is controlled
by or is under common control with the Company and/or (ii) to the extent provided by the Committee, any person or entity in
which the Company has a significant interest as determined by the Committee in its discretion. The term “control” (including,
with correlative meaning, the terms “controlled by” and “under common control with”), as applied to any
person or entity, means the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of such person or entity, whether through the ownership of voting or other securities, by contract or otherwise.

 

(b)              
“Board” means the Board of Directors of the Company. If a Committee has been appointed to administer
this Plan, references herein to the term “Board” shall apply to such Committee to the extent such Committee has been
delegated authority over the applicable subject matter.

 

(c)               
“Business Day” means any day other than a Saturday, a Sunday or a day on which banking institutions
in New York City, New York are authorized or obligated by federal law or executive order to be closed.

 

(d)              
“Cause” shall mean, in the case of a particular Option Award, unless the applicable Option Agreement
states otherwise: (i) if the Participant is a party to an employment or service agreement with the Company or its Affiliates and
such agreement provides for a definition of “cause”, the definition contained therein; or (ii) if no such agreement
exists, or if such agreement does not define “cause”: (a) conviction of, or plea of guilty or no contest to, any felony
or any crime involving moral turpitude or dishonesty or the commission of any other act involving willful malfeasance or material
fiduciary breach with respect to the Company or an Affiliate; (b) participation in a fraud, misappropriation, or embezzlement of
Company and/or its Affiliate funds or property or act of dishonesty against the Company and/or its Affiliate; (c) material violation
of any rule, regulation, policy or plan for the conduct of (as the case may be) any director, officer, employee, member, manager,
consultant or service provider of or to the Company or its Affiliates or its or their business (which, if curable, is not cured
within 5 Business Days after notice thereof is provided to the Participant); (d) conduct that results in or is reasonably likely
to result in harm to the reputation or business of the Company or any of its Affiliates; (e) gross negligence or willful misconduct
with respect to the Company or an Affiliate; (f) material violation of U.S. state, federal or other applicable (including non-U.S.)
securities laws or (g) material breach of Optionholder’s Proprietary Information and Inventions Agreement.

 

    	1

    	 

    
 

 

(e)               
“Change in Control” shall, in the case of a particular Option Award, unless the applicable Option
Agreement states otherwise or contains a different definition of “Change in Control,” be deemed to occur upon:

 

(i)                
An acquisition (whether directly from the Company or otherwise) of any voting securities of the Company (the “Voting
Securities”) by any “Person” (as the term person is used for purposes of Section 13(d) or 14(d)
of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”)), immediately after which
such Person has “Beneficial Ownership” (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more
than fifty percent (50%) of the combined voting power of the Company’s then outstanding Voting Securities.

 

(ii)              
The individuals who constitute the members of the full Board of Directors of the Company cease, by reason of a financing,
merger, combination, acquisition, takeover or other non-ordinary course transaction affecting the Company, to constitute at least
fifty-one percent (51%) of the members of the full Board of Directors of the Company; or

 

(iii)            
Approval by the full Board of Directors of the Company and, if required, stockholders of the Company of, or execution
by the Company of any definitive agreement with respect to, or the consummation of (it being understood that the mere execution
of a term sheet, memorandum of understanding or other non-binding document shall not constitute a Change of Control):

 

(A) A merger, consolidation
or reorganization involving the Company, where either or both of the events described in clauses (i) or (ii) above would
be the result;

 

(B) A liquidation
or dissolution of or appointment of a receiver, rehabilitator, conservator or similar person for, or the filing by a third party
of an involuntary bankruptcy against, the Company; provided, however, that to the extent necessary to comply with Section 409A
of the Code, the occurrence of an event described in this subsection (B) shall not permit the settlement of Restricted Stock
Units granted under this Plan; or

 

    	2

    	 

    
 

(C) An agreement
for the sale or other disposition of all or substantially all of the assets of the Company to any Person (other than a transfer
to a subsidiary of the Company).

 

(f)               
“Code” means the Internal Revenue Code of 1986, as amended, and any successor thereto. Any reference
to a section of the Code shall be deemed to include any regulations promulgated thereunder.

 

(g)              
“Committee” means a committee of one or more members of the Board appointed by the Board in accordance
with subsection 3(c) to administer this Plan.

 

(h)              
“Common Stock” means the common stock, par value $0.001 of the Company.

 

(i)                
“Company” means LabStyle Innovations Corp., a Delaware corporation, and any successor thereto.

 

(j)                
“Consultant” means any person, including an advisor engaged by the Company or an Affiliate to render
consulting or advisory services and who is compensated for such services.

 

(k)              
“Continuous Service” means that the Participant’s service with the Company or an Affiliate,
whether as an Employee, Director or Consultant, is not interrupted or terminated. The Participant’s Continuous Service shall
not be deemed to have terminated merely because of a change in the capacity in which the Participant renders service to the Company
or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service,
provided that there is no interruption or termination of the Participant’s Continuous Service; provided further
that if any Award is subject to Section 409A of the Code, this sentence shall only be given effect to the extent consistent
with Section 409A of the Code. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate
or a Director will not constitute an interruption of Continuous Service. The Committee or its delegate, in its sole discretion,
may determine whether Continuous Service shall be considered interrupted in the case of any leave of absence approved by that party,
including sick leave, military leave. relocation or any other personal or family leave of absence.

 

(l)                
“Covered Employee” means the chief executive officer and the other highest compensated officers of
the Company for whom total compensation is required to be reported to stockholders under the Exchange Act, as determined for purposes
of Section 162(m) of the Code.

 

(m)            
“Director” means a member of the Board.

 

(n)              
“Disability” means that the Participant is unable to engage in any substantial gainful activity by
reason of any medically determinable physical or mental impairment; provided, however, for purposes of determining the term
of an Incentive Stock Option, the term Disability shall have the meaning ascribed to it Section 22(e)(3) of the Code. The determination
of whether an individual has a Disability shall be determined under procedures established by the Committee. Except in situations
where the Committee is determining Disability for purposes of the term of an Incentive Stock Option within the meaning of Section
22(e)(3) of the Code, the Committee may rely on any determination that a Participant is disabled for purposes of benefits under
any long-term disability plan maintained by the Company or any Affiliate in which a Participant participates.

 

    	3

    	 

    
 

 

(o)              
“Employee” means any person, including an Officer or Director, employed by the Company or an Affiliate;
provided, that, for purposes of determining eligibility to receive Incentive Stock Options, an Employee shall mean an employee
of the Company or a parent or subsidiary corporation within the meaning of Code Section 424. Mere service as a Director or payment
of a director’s fee by the Company or an Affiliate shall not be sufficient to constitute “employment” by the
Company or an Affiliate.

 

(p)              
“Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

(q)              
“Fair Market Value” means, as of any date, the value of the Common Stock determined as follows:

 

(i)                
If the Common Stock is listed on any established stock exchange or a national market system, including without limitation,
the New York Stock Exchange or the NASDAQ Stock Market, or quoted on a national exchange or other recognized securities quotation
system (such as the OTC Bulletin Board/OTCQB Market), the Fair Market Value of a share of Common Stock shall be the closing sales
price for such stock as quoted on such exchange, market or quotation system (or the exchange or market with the greatest volume
of trading in the Common Stock) on the last market trading day prior to the day of determination (or the closing price on the date
immediately preceding such date if no sales activity occurred on the day of determination), as reported by Bloomberg or such other
source as the Board deems reliable.

 

(ii)              
In the absence of such markets for the Common Stock, the Fair Market Value shall be determined in good faith by the
Board and such determination shall be conclusive and binding on all persons; provided that, (a) with respect to Options that are
Incentive Stock Options, the Board shall make such determination in accordance with the provisions of Section 422 of the Code and
subject to all applicable U.S. Treasury Regulations and any other applicable guidance promulgated pursuant thereto; (b) with respect
to Options that are not Incentive Stock Options, the determination shall be in accordance with and applicable to U.S. Treasury
Regulations and any other applicable guidance promulgated pursuant thereto.

 

(r)               
“Incentive Stock Option” means an Option intended to qualify as an incentive stock option within
the meaning of Section 422 of the Code and the U.S. Treasury Regulations promulgated thereunder.

 

(s)               
“IPO” means the occurrence of each of the following: (i) either (A) a registration statement covering
an initial public offering or public resale of the Company’s securities by the Company and/or its stockholders is declared
effective by the Securities and Exchange Commission or (B) the Company consummates a “reverse merger” transaction with
a public vehicle and (ii) the company (or its successor) becomes or is a reporting company under the Securities Exchange Act of
1934, as amended, with its common stock listed or quoted on a national exchange or other recognized securities quotation system
(such as the OTC Bulletin Board/OTCQB Market).

 

    	4

    	 

    
 

 

(t)                
“Listing Date” means the first date upon which the Company’s Common Stock is (i) listed (or
approved for listing) upon notice of issuance on any securities exchange,(ii) designated (or approved for designation) upon notice
of issuance as a national market security on an interdealer quotation system if such securities exchange or interdealer quotation
system has been certified or (iii) quoted on any recognized securities quotation system (such as the OTC Bulletin Board/OTCQB Market).

 

(u)              
“Non-Employee Director” means a Director who either (i) is not a current Employee or Officer of the
Company or its parent or a subsidiary, does not receive compensation (directly or indirectly) from the Company or its parent or
a subsidiary for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which
disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (“Regulation
S-K”)), does not possess an interest in any other transaction as to which disclosure would be required under Item
404(a) of Regulation S-K and is not engaged in a business relationship as to which disclosure would be required under Item 404(b)
of Regulation S-K; or (ii) is otherwise considered a “non-employee director” for purposes of Rule 16b-3.

 

(v)              
“Nonstatutory Stock Option” means an Option not intended to qualify as an Incentive Stock Option
and does not meet the requirements of, and is not governed by, the rules of Sections 421 through 424 of the Code.

 

(w)            
“Officer” means a person who is an officer of the Company within the meaning of Section 16 of
the Exchange Act and the rules and regulations promulgated thereunder.

 

(x)              
“Option” means an Incentive Stock Option, a Nonstatutory Stock Option or any other option granted
pursuant to the Plan or any Sub Plan.

 

(y)              
“Option Award” means an award of any Option granted under the Plan or any Sub Plan.

 

(z)               
“Option Agreement” means a written agreement between the Company and an Optionholder evidencing the
terms and conditions of an individual Option Award. Each Option Agreement shall be subject to the terms and conditions of the Plan.

 

(aa)          
“Optionholder” means a person to whom an Option is granted pursuant to the Plan or, if applicable,
such other person who holds an outstanding Option.

 

(bb)         
“Outside Director” means a Director who either (i) is not a current employee of the Company or an
“affiliated corporation” (within the meaning of Treasury Regulations promulgated under Section 162(m) of the Code),
is not a former employee of the Company or an “affiliated corporation” receiving compensation for prior services (other
than benefits under a tax qualified pension plan), was not an officer of the Company or an “affiliated corporation”
at any time and is not currently receiving direct or indirect remuneration from the Company or an “affiliated corporation”
for services in any capacity other than as a Director or (ii) is otherwise considered an “outside director” for purposes
of Section 162(m) of the Code.

 

    	5

    	 

    
 

 

(cc)           
“Parent” means any corporation (other than the Company) in an unbroken chain of corporations or other
entities ending with the Company, if each of the corporations or other entities (other than the Company) owns stock possessing
50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation
or other entity that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing
as of such date.

 

(dd)         
“Participant” means a person to whom an Option Award is granted pursuant to the Plan or, if applicable,
such other person who holds an outstanding Option Award.

 

(ee)           
“Plan” means this Labstyle Innovations Corp. 2012 Equity Incentive Plan.

 

(ff)            
“Rule 16b-3” means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3,
as in effect from time to time.

 

(gg)          
“Securities Act” means the Securities Act of 1933, as amended.

 

(hh)         
“Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations
or other entities beginning with the Company, if each of the corporations or other entities other than the last corporation or
entity in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one
of the other corporations or entities in such chain. A corporation or other entity that attains the status of a Subsidiary on a
date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date.

 

(ii)              
“Sub Plan” means any sub plan subject to the terms of the Plan.

 

(jj)             
“Ten Percent Stockholder” means a person who owns (or is deemed to own pursuant to Section 424(d)
of the Code) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company
or of any of its Affiliates.

 

3.                 
Administration.

 

(a)              
Administration by Board. The Board shall administer the Plan unless and until the Board delegates administration to
a Committee, as provided in subsection 3(c). Any interpretation of the Plan by the Board and any decision by the Board under the
Plan shall be final and binding on all persons.

 

(b)              
Powers of Board. The Board shall have the power, subject to, and within the limitations of, the express provisions of
the Plan:

 

    	6

    	 

    
 

 

(i)                
to determine from time to time which of the persons eligible under the Plan shall be granted Option Awards; when and
how each Option Award shall be granted; what type or combination of types of Option Award shall be granted; the provisions and
terms of each Option Award granted (which need not be identical), including the time or times when a person shall be permitted
to receive Common Stock pursuant to an Option Award; the number of shares of Common Stock with respect to which an Option Award
shall be granted to each such person; and to prescribe the terms and conditions of each Option Award, including, without limitation,
the exercise price and medium of payment (including Options exercisable via “cashless exercise”) and vesting provisions,
and to specify the provisions of the Option Award relating to such grant;

 

(ii)              
to construe and interpret (i) the Plan and apply its provisions and (ii) Option Awards granted under it, and to establish,
amend and revoke rules and regulations for its administration. The Board, in the exercise of this power, may correct any defect,
omission or inconsistency in the Plan or in any Option Agreement, in a manner and to the extent it shall deem necessary or expedient
to make the Plan fully effective;

 

(iii)            
to promulgate, amend and rescind rules and regulations relating to the administration of the Plan or an Option Award;

 

(iv)            
to authorize any person to execute, on behalf of the Company, any instrument required to carry out the purposes of the
Plan;

 

(v)              
to delegate its authority to one or more Officers of the Company with respect to Option Awards that do not involve Covered
Employees or “insiders” within the meaning of Section 16 of the Exchange Act;

 

(vi)            
to determine whether each Option is to be an Incentive Stock Option or a Nonstatutory Stock Option;

 

(vii)          
to amend any outstanding Option Awards, including for the purpose of modifying the time or manner of vesting, or the
term of any outstanding Option Award; provided, however, that if any such amendment impairs a Participant’s rights
or increases a Participant’s obligations under his or her Option Award or creates or increases a Participant’s federal
income tax liability with respect to an Option Award, such amendment shall also be subject to the Participant’s consent;

 

(viii)        
to determine the duration and purpose of leaves of absences which may be granted to a Participant without constituting
termination of their employment for purposes of the Plan, which periods shall be no shorter than the periods generally applicable
to Employees under the Company’s employment policies;

 

(ix)            
to make decisions with respect to outstanding Option Awards that may become necessary upon a change in corporate control
or an event that triggers anti-dilution adjustments;

 

    	7

    	 

    
 

 

(x)              
to exercise discretion to make any and all other determinations which it determines to be necessary or advisable for
the administration of the Plan; and

 

(xi)            
generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the
best interests of the Company which are not in conflict with the provisions of the Plan.

 

(c)               
Delegation to Committee.

 

(i)                
General. The Board may delegate administration of the Plan to a Committee or Committees of one (1) or more members of
the Board, and the term “Committee” shall apply to any person or persons to whom such authority has been
delegated. If administration is delegated to a Committee, the Committee shall have, in connection with the administration of the
Plan, the powers theretofore possessed by the Board, including the power to delegate to a subcommittee any of the administrative
powers the Committee is authorized to exercise (and references in this Plan to the Board shall thereafter be to the Committee or
subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from
time to time by the Board. The Board may abolish the Committee at any time and revest in the Board the administration of the Plan.
From time to time, the Board may increase or decrease the size of the Committee, add additional members to, remove members (with
or without cause) from, appoint new members in substitution therefor, and fill vacancies, however caused, in the Committee. The
Committee shall act pursuant to a vote of the majority of its members or, in the case of a Committee comprised of only two members,
the unanimous consent of its members, whether present or not, or by the written consent of the majority of its members and minutes
shall be kept of all of its meetings and copies thereof shall be provided to the Board. Subject to the limitations prescribed by
the Plan and the Board, the Committee may establish and follow such rules and regulations for the conduct of its business as it
may determine to be advisable

 

(ii)              
Committee Composition when Common Stock is Publicly Traded. At such time as the Common Stock is publicly traded, unless
otherwise determined by the Board not to comply with the exemption requirements of rule 16b-3 and/or Section 162(m) of the Code,
a Committee shall consist solely of two (2) or more Outside Directors, in accordance with Section 162(m) of the Code, and/or solely
of two (2) or more Non-Employee Directors, in accordance with Rule 16b-3. Within the scope of such authority, the Board or the
Committee may (1) delegate to a committee of one or more members of the Board who are not Outside Directors the authority to grant
Option Awards to eligible persons who are either (a) not then Covered Employees and are not expected to be Covered Employees at
the time of recognition of income resulting from such Option Award or (b) not persons with respect to whom the Company wishes to
comply with Section 162(m) of the Code and/or (2) delegate to a committee of one or more members of the Board who are not Non-Employee
Directors the authority to grant Option Awards to eligible persons who are not then subject to Section 16 of the Exchange Act.
Nothing herein shall create an inference that an Option Award is not validly granted under the Plan in the event Option Awards
are granted under the Plan by a compensation committee of the Board that does not at all times consist solely of two or more Non-Employee
Directors who are also Outside Directors.

 

    	8

    	 

    
 

 

4.                 
Shares Subject to the Plan.

 

(a)               Share
Reserve. Subject to the provisions of Section 10 relating to adjustments upon changes in Common Stock, the Common Stock
that may be issued pursuant to Option Awards shall not exceed in the aggregate of 2,860,000 shares of Common
Stock. During the terms of the Option Awards, the Company shall keep available at all times the number of shares of Common
Stock required to satisfy such Awards.

 

(b)              
Reversion of Shares to the Share Reserve. If any Option Award shall for any reason expire or otherwise terminate, in
whole or in part, without having been exercised in full, the shares of Common Stock not acquired under such Option Award shall
revert to the Plan and again become available for issuance under the Plan. Notwithstanding anything to the contrary contained herein,
shares subject to an Option Award under the Plan shall not again be made available for issuance or delivery under the Plan if such
shares are (a) shares tendered in payment of an Option, (b) shares delivered or withheld by the Company to satisfy any tax withholding
obligation, or (c) shares covered by any other Option Awards that were not issued upon the settlement of the Award.

 

(c)               
Source of Shares. The shares of Common Stock subject to the Plan may be, in whole or in part, authorized and unissued
shares, treasury shares or shares reacquired by the Company in any manner.

 

(d)              
Subject to adjustment in accordance with Section 10,
no Participant shall be granted, during any one (1) year period, Options to purchase Common Stock with respect to more than 2,860,000
shares of Common Stock in the aggregate or any other Option Awards with respect to more than 2,860,000 shares of Common
Stock in the aggregate. If an Option Award is to be settled in cash, the number of shares of Common Stock on which the Option Award
is based shall count toward the individual share limit set forth in this Section 4.

 

(e)               
Any shares of Common Stock subject to an Option Award that is canceled, forfeited or expires prior to exercise or realization,
either in full or in part, shall again become available for issuance under the Plan.

 

5.                 
Eligibility.

 

(a)              
Eligibility for Specific Option Awards. Incentive Stock Options may be granted only to Employees. Options Awards other
than Incentive Stock Options may be granted to Employees, Directors and Consultants.

 

(b)              
Ten Percent Stockholders.

 

(i)                
A Ten Percent Stockholder shall not be granted an Incentive Stock Option unless the exercise price of such Option is
at least one hundred ten percent (110%) of the Fair Market Value of the Common Stock at the date of grant and the Option is not
exercisable after the expiration of five (5) years from the date of grant.

 

    	9

    	 

    
 

 

(ii)              
Prior to the Listing Date, a Ten Percent Stockholder shall not be granted a Nonstatutory Stock Option unless the exercise
price of such Option is at least (i) one hundred ten percent (110%) of the Fair Market Value of the Common Stock at the date of
grant.

 

(c)               
Consultants.

 

(i)                
Prior to the Listing Date, a Consultant shall not be eligible for the grant of an Option Award if, at the time of grant,
either the offer or the sale of the Company’s securities to such Consultant is not exempt under Rule 701 of the Securities
Act (“Rule 701”) because of the nature of the services that the Consultant is providing to the Company,
or because the Consultant is not a natural person, or as otherwise provided by Rule 701, unless the Company determines that such
grant need not comply with the requirements of Rule 701 and will satisfy another exemption under the Securities Act as well as
comply with the securities laws of all other relevant jurisdictions.

 

(ii)               From and
after the Listing Date, a Consultant shall not be eligible for the grant of an Option Award if, at the time of grant, a Form S-8
Registration Statement under the Securities Act (“Form S-8”) is not available to register either the
offer or the sale of the Company’s securities to such Consultant because of the nature of the services that the Consultant
is providing to the Company, or because the Consultant is not a natural person, or as otherwise provided by the rules governing
the use of Form S-8, unless the Company determines both (i) that such grant (A) shall be registered in another manner under the
Securities Act (e.g., on a Form S-3 Registration Statement) or (B) does not require registration under the Securities Act
in order to comply with the requirements of the Securities Act, if applicable, and (ii) that such grant complies with the securities
laws of all other relevant jurisdictions.

 

(iii)              As of
April 7, 1999, Rule 701 and Form S-8 generally are available to consultants and advisors only if (i) they are natural persons;
(ii) they provide bona fide services to the issuer, its parents, its majority-owned subsidiaries or majority-owned subsidiaries
of the issuer’s parent; and (iii) the services are not in connection with the offer or sale of securities in a capital-raising
transaction, and do not directly or indirectly promote or maintain a market for the issuer’s securities.

 

6.                 
Option Provisions.

 

Each Option shall be
in such form and shall contain such terms and conditions as the Board shall deem appropriate and set forth in the Option Agreement
approved by the Board. All Options shall be separately designated as Incentive Stock Options or Nonstatutory Stock Options of U.S.
Participants or 3(i) Option and Options granted under Section 102 of the Ordinance (as defined under the applicable Sub Plan) for
Israeli Participants at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued
for shares of Common Stock purchased on exercise of each type of Option. No Option shall be treated as an Incentive Stock Option
unless this Plan has been approved by the stockholders of the Company in a manner intended to comply with the stockholder approval
requirements of Section 422(b)(1) of the Code, provided that any Option intended to be an Incentive Stock Option shall not
fail to be effective solely on account of a failure to obtain such approval, but rather such Option shall be treated as a Nonstatutory
Stock Option unless and until such approval is obtained. The provisions of separate Options need not be identical, but each Option
shall include (through incorporation of provisions hereof by reference in the Option or otherwise) the substance of each of the
following provisions:

 

    	10

    	 

    
 

 

(a)              
Procedure for Exercise. An Option shall be deemed exercised when the Company receives (i) written or
electronic notice of exercise in accordance with the Option Agreement) from the person entitled to exercise the Option, and (ii) full
payment for the shares with respect to which the Option is exercised, together with any applicable withholding taxes. Full payment
may consist of any consideration and method of payment authorized by the Board and permitted by the Option Agreement and the Plan.
The exercise price shall be denominated in the currency of the primary economic environment of, either the Company or the participant
(that is the functional currency of the Company or the currency in which the Participant is paid) as determined by the Company.

 

(b)              
Until an IPO, shares issued upon the exercise of Option shall be voted by an irrevocable proxy (attached to the Option
Agreement) (the “Proxy”) pursuant to the directions of the Board, such Proxy to be assigned to representatives
designated by Board (the “Representatives”). Such Representatives shall be indemnified and held harmless
by the Company against any cost or expense (including counsel fees) reasonably incurred by him/her, or any liability (including
any sum paid in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection
with the voting of the Proxy unless arising out of such Representative’s own fraud or bad faith, to the extent permitted
by applicable law. Such indemnification shall be in addition to any rights of indemnification the Representative(s) may have as
a director or otherwise under the Company’s Certificate of Incorporation and By-Laws, any agreement, any vote of shareholders
or disinterested directors, insurance policy or otherwise.

 

(c)               
Term. Subject to the provisions of subsection 5(b) regarding Ten Percent Stockholders, no Option shall be exercisable
after the expiration of ten (10) years from the date it was granted, or the date set forth at the Option Agreement, as earlier.

 

(d)              
Exercise Price of an Incentive Stock Option. Subject to the provisions of subsection 5(b) regarding Ten Percent Stockholders,
the exercise price of each Incentive Stock Option shall be not less than one hundred percent (100%) of the Fair Market Value of
the Common Stock subject to the Option on the date the Option is granted or such other amount as may be required pursuant to the
Code. Notwithstanding the foregoing, an Incentive Stock Option may be granted with an exercise price lower than that set forth
in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying
the provisions of Section 424(a) of the Code.

 

(e)               
Exercise Price of a Nonstatutory Stock Option. Subject to the provisions of subsection 5(b) regarding Ten Percent Stockholders,
the exercise price of each Nonstatutory Stock Option granted prior to the Listing Date shall be not less than one hundred percent
(100%) of the Fair Market Value of the Common Stock subject to the Option on the date the Option is granted or such other amount
as may be required pursuant to the Code. The exercise price of each Nonstatutory Stock Option granted on or after the Listing Date
shall be not less than one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the Option on the date
the Option is granted. Notwithstanding the foregoing, a Nonstatutory Stock Option may be granted with an exercise price lower than
that set forth in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option
in a manner satisfying the provisions of Section 424(a) of the Code.

 

    	11

    	 

    
 

 

(f)               
Consideration. The purchase price of Common Stock acquired pursuant to an Option shall be paid, to the extent permitted
by applicable statutes and regulations, either (i) in cash and/ or check at the time the Option is exercised or (ii) at the discretion
of the Board at the time of the grant of the Option (or subsequently in the case of a Nonstatutory Stock Option) (1) by delivery
to the Company of other Common Stock, or (2) in any other form of legal consideration that may be acceptable to the Board. The
Board shall have the authority to postpone the date of payment on such terms as it may determine.

 

(g)              
Transferability of an Incentive Stock Option. An Incentive Stock Option shall not be transferable except by will or
by the laws of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder.
Notwithstanding the foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the
Company, designate a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the
Option.

 

(h)              
Transferability of a Nonstatutory Stock Option. A Nonstatutory Stock Option granted prior to the Listing Date shall
not be transferable except by will or by the laws of descent and distribution and, to the extent provided in the Option Agreement,
and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. A Nonstatutory Stock Option granted
on or after the Listing Date shall be transferable to the extent provided in the Option Agreement. If the Nonstatutory Stock Option
does not provide for transferability, then the Nonstatutory Stock Option shall not be transferable except by will or by the laws
of descent and distribution and shall be exercisable during the lifetime of the Optionholder only by the Optionholder. Notwithstanding
the foregoing, the Optionholder may, by delivering written notice to the Company, in a form satisfactory to the Company, designate
a third party who, in the event of the death of the Optionholder, shall thereafter be entitled to exercise the Option

 

(i)                
Vesting Generally. The total number of shares of Common Stock subject to an Option may, but need not, vest and therefore
become exercisable in periodic installments that may, but need not, be equal. The Option may be subject to such other terms and
conditions on the time or times when it may be exercised (which may be based on performance or other criteria) as the Board may
deem appropriate. The vesting provisions of individual Options may vary.

 

(j)                
Termination of Continuous Service. In the event an Optionholder’s Continuous Service terminates (other than upon
the Optionholder’s death or Disability), and unless otherwise specified in the applicable Option Agreement, the Optionholder
may exercise his or her Option (to the extent that the Optionholder was entitled to exercise such Option as of the date of termination)
but only within such period of time ending on the earlier of (i) the date three (3) months following the termination of the Optionholder’s
Continuous Service (or such shorter period specified in the Option Agreement or such different period as the Board may prescribe,
which period shall not be less than thirty (30) days for Options granted prior to the Listing Date unless such termination is for
Cause), or (ii) the expiration of the term of the Option as set forth in the Option Agreement. If, after termination, the Optionholder
does not exercise his or her Option within the time specified in the Option Agreement, the Option shall terminate.

 

    	12

    	 

    
 

 

(k)               Extension
of Termination Date. An Optionholder’s Option Agreement may also provide that if the exercise of the Option
following the termination of the Optionholder’s Continuous Service (other than upon the Optionholder’s death or
Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the
registration requirements under the Securities Act, then the Option shall terminate on the earlier of (i) the expiration of
the term of the Option set forth in subsection 6(c) or (ii) the expiration of a period of three (3) months after the
termination of the Optionholder’s Continuous Service during which the exercise of the Option would not be in violation
of such registration requirements.

 

(l)                
Disability of Optionholder. Unless otherwise provided in its Option Agreement, in the event that an Optionholder’s
Continuous Service terminates as a result of the Optionholder’s Disability, the Optionholder may exercise his or her Option
(to the extent that the Optionholder was entitled to exercise such Option as of the date of termination), but only within such
period of time ending on the earlier of (i) the date twelve (12) months following such termination (or such shorter period specified
in the Option Agreement which period shall not be less than six (6) months for Options granted prior to the Listing Date or such
longer period as specified in the Option Agreement and approved by the Board) or (ii) the expiration of the term of the Option
as set forth in the Option Agreement. If, after termination, the Optionholder does not exercise his or her Option within the time
specified herein, the Option shall terminate.

 

(m)            
Death of Optionholder. Unless otherwise provided in its Option Agreement, in the event (i) an Optionholder’s
Continuous Service terminates as a result of the Optionholder’s death or (ii) the Optionholder dies within the period (if
any) specified in the Option Agreement after the termination of the Optionholder’s Continuous Service, then the Option may
be exercised (to the extent the Optionholder was entitled to exercise such Option as of the date of death) by the Optionholder’s
estate, by a person who acquired the right to exercise the Option by bequest or inheritance or by a person designated to exercise
the option upon the Optionholder’s death pursuant to subsection 6(g) or 6(h), but only within the period ending on the earlier
of (1) the date Twelve (12) months following the date of death (or such shorter period specified in the Option Agreement which
period shall not be less than six (6) months for Options granted prior to the Listing Date as specified in the Option Agreement
and approved by the Board) or (2) the expiration of the term of such Option as set forth in the Option Agreement. If, after death,
the Option is not exercised within the time specified herein, the Option shall terminate.

 

    	13

    	 

    
 

(n)              
Termination of Continuous Service for Cause. Notwithstanding Sections (j)-(m) above, in the event of termination of
Participant’s employment with the Company or any of its Affiliates, or if applicable, the termination of services given to
the Company or any of its Affiliates by Consultants of the Company or any of its Affiliates for Cause (as defined above), all outstanding
Option Awards granted to such Participant (whether vested or not) will immediately expire and terminate on the date of such termination
and the holder of Option Awards shall not have any right in connection to such outstanding Option Awards, unless otherwise determined
by the Board. The Shares of Common Stock covered by such Option Awards shall revert to the Plan.

 

(o)              
Compliance With Laws, etc. Notwithstanding the foregoing, following the Listing Date, in no event shall a Participant
be permitted to exercise an Option in a manner that the Committee determines would violate the Sarbanes-Oxley Act of 2002, if applicable,
or any other applicable law or the applicable rules and regulations of the Securities and Exchange Commission or the applicable
rules and regulations of any securities exchange, inter-dealer quotation system or other recognized securities quotation system
on which the securities of the Company are listed, quoted or traded.

 

7.                 
Covenants of the Company.

 

(a)              
Availability of Shares. During the terms of the Option Awards, the Company shall keep available at all times the number
of authorized shares of Common Stock required to satisfy such Option Awards.

 

(b)              
Securities Law Compliance. The Company shall seek to obtain from each regulatory commission or agency having jurisdiction
over the Plan such authority as may be required to grant Option Awards and to issue and sell shares of Common Stock upon exercise
of the Option Awards; provided, however, that this undertaking shall not require the Company to register under the Plan, any Option
Award or any Common Stock issued or issuable pursuant to any such Option Award under the Securities Act. If, after reasonable efforts,
the Company is unable to obtain from any such regulatory commission or agency the authority which counsel for the Company deems
necessary for the lawful issuance and sale of Common Stock under the Plan, the Company shall be relieved from any liability for
failure to issue and sell Common Stock upon exercise of such Option Awards unless and until such authority is obtained.

 

8.                 
Use of Proceeds from Stock.

 

Proceeds from the sale
of Common Stock pursuant to Option Awards shall constitute general funds of the Company.

 

9.                 
Miscellaneous.

 

(a)              
Acceleration of Exercisability and Vesting. Subject to applicable law, the Board in its sole discretion shall have the
power to accelerate the time at which a certain Option Award may first be exercised or the time during which a Option Award or
any part thereof will vest in accordance with the Plan, notwithstanding the provisions in the Option Award stating the time at
which it may first be exercised or the time during which it will vest.

 

    	14

    	 

    
 

 

(b)              
Stockholder Rights. No Participant shall be deemed to be the holder of, or to have any of the rights of a holder with
respect to, any shares of Common Stock subject to such Option Award unless and until such Participant has satisfied all requirements
for exercise of the Option Award pursuant to its terms.

 

(c)               
No Employment or other Service Rights. Nothing in the Plan or any instrument executed or Option Award granted pursuant
thereto shall confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect
at the time the Option Award was granted or shall affect the right of the Company or an Affiliate to terminate (i) the employment
of an Employee with or without notice and with or without Cause, (ii) the service of a Consultant pursuant to the terms of such
Consultant’s agreement with the Company or an Affiliate or (iii) the service of a Director pursuant to the Bylaws of the
Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate
is incorporated, as the case may be.

 

(d)              
Incentive Stock Option $100,000 Limitation. To the extent that the aggregate Fair Market Value (determined at the time
of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder
during any calendar year (under all plans of the Company and its Affiliates) exceeds one hundred thousand dollars ($100,000), the
Options or portions thereof which exceed such limit (according to the order in which they were granted) shall be treated as Nonstatutory
Stock Options.

 

(e)               
Investment Assurances. The Company may require a Participant, as a condition of exercising or acquiring Common Stock
under any Option Award, (i) to give written assurances satisfactory to the Company as to the Participant’s knowledge and
experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company
who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together
with the purchaser representative, the merits and risks of exercising the Option Award; and (ii) to give written assurances satisfactory
to the Company stating that the Participant is acquiring Common Stock subject to the Option Award for the Participant’s own
account and not with any present intention of selling or otherwise distributing the Common Stock. The foregoing requirements, and
any assurances given pursuant to such requirements, shall be inoperative if (1) the issuance of the shares of Common Stock upon
the exercise or acquisition of Common Stock under the Option Award has been registered under a then currently effective registration
statement under the Securities Act or (2) as to any particular requirement, a determination is made by counsel for the Company
that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may, upon advice
of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate
in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common
Stock.

 

    	15

    	 

    
 

 

(f)               
Withholding Obligations. The Company or any Subsidiary or Affiliate may take such action as it may deem necessary or
appropriate, in its discretion, for the purpose of or in connection with withholding of any taxes which the Company or any Subsidiary
or Affiliate is required by any applicable law to withhold in connection with any Option Awards (collectively, “Withholding
Obligations”). Such actions may include, without limitation, (i) requiring a Participant to remit to the Company
in cash an amount sufficient to satisfy such Withholding Obligations; (ii) subject to applicable law, allowing the Participant
to provide shares of Common Stock to the Company, in an amount that at such time, reflects a value that the Board determines to
be sufficient to satisfy such Withholding Obligations; (iii) withholding shares of Common Stock otherwise issuable upon the exercise
of an Option Award at a value which is determined by the Board to be sufficient to satisfy such Withholding Obligations; or (iv)
any combination of the foregoing. The Company shall not be obligated to allow the exercise of any Option Award by or on behalf
of a Participant until all tax consequences arising from the exercise of such Option Award are resolved in a manner acceptable
to the Company.

 

10.             
Adjustment upon Changes in Stock.

 

(a)              
Capitalization Adjustments. If any change is made in the Common Stock generally or the Common Stock subject to the
Plan, or the Common Stock subject to any Option Award, without the receipt of consideration by the Company (through merger, consolidation,
reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, stock split, liquidating
dividend, combination of shares, exchange of shares, change in corporate structure or other transaction not involving the receipt
of consideration by the Company), the Plan will be appropriately adjusted in the class(es) and maximum number of securities subject
to the Plan pursuant to subsection 4(a) and the maximum number of securities subject to award to any person pursuant to subsection
5(c), and the outstanding Option Awards will be appropriately adjusted in the class(es) and number of securities and price per
share of Common Stock subject to such outstanding Option Awards. The Board shall make such adjustments, and its determination
shall be final, binding and conclusive. (For this purpose, the conversion of any convertible securities of the Company shall not
be treated as a transaction “without receipt of consideration” by the Company.)

 

(b)              
Dissolution or Liquidation. In the event of a dissolution or liquidation of the Company, then the Company shall immediately
notify Participant who hold outstanding Option Awards of such dissolution or liquidation, and such Participant shall have
thirty (30) days to exercise any outstanding vested options held by him at that time. Upon the expiration of such thirty days period,
all remaining outstanding options shall terminate immediately.

 

(c)               
Change in Control. In the event of a Change in Control, then, without the consent or action required of any holder of
an Option Award (in such holder’s capacity as such):

 

(i)                
Any surviving corporation or acquiring corporation or any parent or affiliate thereof, as determined by the Board in
its discretion, shall assume or continue any Option Awards outstanding under the Plan in all or in part or shall substitute to
similar stock awards in all or in part; or

 

    	16

    	 

    
 

 

(ii)              
In the event any surviving corporation or acquiring corporation does not assume or continue any Option Awards or substitute
to similar stock awards, for those outstanding under the Plan, then: (a) all unvested Option Awards shall expire (b) vested options
shall terminate if not exercised at or prior to such Change in Control; or

 

(iii)            
Upon Change in Control the Board may, in its sole discretion, accelerate the vesting, partially or in full, in the sole
discretion of the Board and on a case-by-case basis of one or more Option Awards as the Board may determine to be appropriate prior
to such events.

 

(d)              
Notwithstanding the above, in case of Change in Control, in the event all or substantially all of the shares of the
Company are to be exchanged for securities of another Company, then each holder of an Option Award shall be obliged to sell or
exchange, as the case may be, any shares such holder hold or purchased under the Plan, in accordance with the instructions issued
by the Board, whose determination shall be final.

 

(e)               
Each holder of an Option Award acknowledges that in the event that the Company’s shares shall be listed, quoted
or registered for trading in any public market, the rights of such holder to sell the shares may be subject to certain limitations
(including a lock-up period), as may be requested by the Company or its underwriters, and the holder of such Option Award unconditionally
agrees and accepts any such limitations.

 

(f) Notwithstanding
the above said, the Board may, in its sole discretion, decide other terms regarding the treatment of the outstanding Option Awards,
in case of Change in Control and/or in case of IPO.

 

11.             
Shares subject to right of first refusal. 

 

(a)              
Notwithstanding anything to the contrary in the Certificate of Incorporation and the By-Laws of the Company, none of
the Optionholders shall have a right of first refusal or preemptive right in relation with any sale of shares in the Company.

 

(b)              
Sale of shares of Common Stock by the Participant shall be subject to the right of first refusal of other shareholders
as set forth in the Certificate of Incorporation and/or the By-Laws of the Company.

 

(c)               
Prior to an IPO, and in addition to the right of first refusal, any transfer of shares of Common Stock of the Company
by a Participant shall require the approval of the Board as to the transferee. The Board may refuse to approve the transfer of
shares of Common Stock to any competitor of the Company or to any other person or entity the Board determines, in its discretion,
may be detrimental to the Company.

 

(d)              
Notwithstanding anything to the contrary unless otherwise determined by the Board, until such time as the Company shall
complete an IPO, a Participant shall not have the right to sell Common Stock unless otherwise determined by the Board.

 

    	17

    	 

    
 

 

12.             
Amendment of the Plan and Option Awards.

 

(a)              
Amendment of Plan. The Board at any time, and from time to time, may amend the Plan. However, except as provided in
Section 11 relating to adjustments upon changes in Common Stock, no amendment shall be effective unless approved by the stockholders
of the Company to the extent stockholder approval is necessary to satisfy the requirements of Section 422 of the Code or any other
applicable laws, rules and regulations.

 

(b)              
Stockholder Approval. The Board may, in its sole discretion, submit any other amendment to the Plan for stockholder
approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of Section 162(m) of the Code
and the regulations thereunder regarding the exclusion of performance-based compensation from the limit on corporate deductibility
of compensation paid to certain executive officers.

 

(c)               
Contemplated Amendments. It is expressly contemplated that the Board may amend the Plan in any respect the Board deems
necessary or advisable to provide eligible Employees with the maximum benefits provided or to be provided under the provisions
of the Code and the regulations promulgated thereunder relating to Incentive Stock Options and/or to bring the Plan and/or Incentive
Stock Options granted under it into compliance therewith.

 

(d)              
No Impairment of Rights. Rights under any Option Award granted before amendment of the Plan shall not be impaired by
any amendment of the Plan unless (i) the Company requests the consent of the Participant and (ii) the Participant consents in writing.

 

(e)               
Amendment of Option Awards. The Board at any time, and from time to time, may amend the terms of any one or more Option
Awards; provided, however, that the rights under any Option Award shall not be impaired by any such amendment unless (i) the Company
requests the consent of the Participant and (ii) the Participant consents in writing (such consent to not be unreasonably withheld
or delayed). 

 

13.             
Termination or Suspension of the Plan.

 

(a)              
Plan Term. The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate
on the day before the tenth (10th) anniversary of the date the Plan is adopted by the Board or approved by the stockholders of
the Company, whichever is earlier. No Option Awards may be granted under the Plan while the Plan is suspended or after it is terminated.

 

(b)              
No Impairment of Rights. Suspension or termination of the Plan shall not impair rights and obligations under any Option
Award granted while the Plan is in effect except with the written consent of the Participant.

 

14.             
Tax Consequences

 

(a)Any
tax consequences arising from the grant or exercise of any Option, from the payment for Common Stock covered thereby or from any
other event or act (of the Company and/or its Affiliates, or the Participant), hereunder, shall be borne solely by the Participant.
The Company and/or its Affiliates shall withhold taxes according to the requirements under the applicable laws, rules, and regulations,
including withholding taxes at source. Furthermore, the Participant shall agree to indemnify the Company and/or its Affiliates
and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without
limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Participant.

 

    	18

    	 

    
 

 

(b)The
Company shall not be required to release any share certificate to a Participant until all required payments have been fully made.

 

15.             
Notice To Company Of Disqualifying Disposition

 

Without derogating
from all of the above, each Employee who receives an Incentive Stock Option must agree to notify the Company in writing immediately
after the Employee makes a Disqualifying Disposition of any Common Stock acquired upon the exercise of an Incentive Stock Option.
A “Disqualifying Disposition” is any disposition (including any sale) of such Common Stock before the
later of (a) two (2) years after the date the Employee was granted the Incentive Stock Option, or (b) one (1) year after the date
the Employee acquired Common Stock by exercising the Incentive Stock Option. If the Employee has died before such Share is sold,
these holding period requirements do not apply and no Disqualifying Disposition can occur thereafter.

 

16.             
Effective Date of Plan.

 

The Plan shall take
effect upon its adoption by the Board (the “Effective Date”), except that solely with respect to grants
of Incentive Stock Options the Plan shall also be subject to approval within one year of the Effective Date, by a majority of the
votes cast on the proposal at a meeting or a written consent of shareholders. Failure to obtain approval by the shareholders shall
not in any way derogate from the valid and binding effect of any grant of an Option Award, which is not an Incentive Stock Option.
Upon approval of the Plan by the shareholders of the Company as set forth above, all Incentive Stock Options granted under the
Plan on or after the Effective Date shall be fully effective as if the shareholders of the Company had approved the Plan on the
Effective Date. Notwithstanding the foregoing, in the event that approval of the Plan by the shareholders of the Company is required
under applicable law, in connection with the application of certain tax treatment or pursuant to applicable stock exchange rules
or regulations or otherwise, such approval shall be obtained within the time required under the applicable law.

 

17.             
Choice of Law.

 

(i)                
Choice of Law. This Plan, all Option Awards and all documents evidencing awards and all other related documents will
be governed by, and construed in accordance with, the laws of the State of Delaware, provided that the tax treatment and
the tax rules and regulations applying to a grant in any specific jurisdiction shall be the local tax laws of such jurisdiction
in addition to the Federal income tax laws of the United States.

 

    	19

    	 

    
 

 

(ii)              
Israeli Participants. Any grant of an Option Award to an Israeli Employee or to an Israeli Non-Employee (as each of
such terms is defined in the Sub Plan applicable to Israeli Participants) shall be made in accordance with and pursuant to the
provisions of this Plan and the Sub Plan applicable to Israeli Participants.

 

(iii)            
Severability. If it is determined that any provision of this Plan or an Option Agreement is invalid and unenforceable,
the remaining provisions of this Plan and/or the Option Agreement, as applicable, will continue in effect.

 

 

 

# # #

 

    	20Exhibit 10.1

 

 

PLACEMENT AGENCY
AGREEMENT

 

September 8, 2011

 

Spencer Trask Ventures, Inc.

750 Third Avenue, 11th Floor

New York, New York 10017

 

Ladies and Gentlemen:

 

LabStyle Innovations
Corp., a Delaware corporation (the “Company”), hereby confirms its agreement (this “Agreement”)
with Spencer Trask Ventures, Inc., a Delaware corporation (the “Placement Agent”) with respect to the
matters set forth herein as follows:

 

1. Offering.

 

(a) The Company
will offer (the “Offering”) for sale through the Placement Agent, as exclusive agent for the Company, and its
selected dealers, if any, a minimum of ten (10) units ($500,000) (the “Minimum Amount”) and a maximum of forty
(40) units ($2,000,000) (the “Maximum Amount”). Each unit (a “Unit”) shall be priced at price
of $50,000 per Unit and shall consist of (i) 50,000 shares of common stock, par value $0.0001 per share, of the Company (the “Common
Stock”) and (ii) a five year warrant (each a “Warrant” and collectively, the “Warrants”)
to purchase 50,000 shares of Common Stock at an exercise price of $1.50 per share. The Common Stock shall have the rights and privileges
described in the Memorandum (as hereinafter defined). By mutual agreement, the Company and the Placement Agent may elect to increase
the Maximum Amount and sell up to an additional twenty (20) Units for an aggregate purchase price of up to $1,000,000 to cover
over-allotments. The shares of Common Stock included as part of the Units are referenced to herein as the “Shares.”

 

(b) Placement of
the Units by the Placement Agent will be made on a “reasonable efforts,” “all-or-none” basis with respect
to the Minimum Amount and on a “reasonable efforts” basis as to all Units in excess of the Minimum Amount. The minimum
subscription for Units shall be one (1) Unit; provided, however, that the Company may, in its discretion, sell fractional
Units. The Units will be offered to potential subscribers, which may include related parties of the Placement Agent or the Company,
commencing on the date of the Memorandum (the “Commencement Date”) and continuing until October 31, 2011; provided,
however, that the Offering may be extended by mutual agreement of the Placement Agent and the Company until a date no later
than December 30, 2011, or as terminated earlier as provided herein (the “Offering Period”). The date on which
the Offering Period shall terminate or expire shall be referred to as the “Termination Date.” A Final Closing
(as hereinafter defined) may be held within ten business days of the Termination Date.

 

(c) Subscriptions
for the Units will be accepted by the Company at a price of $50,000 per Unit (the “Offering Price”) or such
price proportional to the fractional Units offered in accordance with Section 1(b) hereof; provided, however, that
the Placement Agent shall not tender to the Company and the Company shall not accept subscriptions from, or sell Units to, any
persons or entities that do not qualify as (or are not reasonably believed to be) “accredited investors,” as such term
is defined in Rule 501 of Regulation D promulgated under Section 4(2) (“Regulation D”) of the Securities Act
of 1933, as amended (the “1933 Act”).

 

    	1

    	 

    
 

 

(d) The offering
of the Units will be made by the Placement Agent on behalf of the Company solely pursuant to the Memorandum, and the Investor Presentation
(as defined below), which at all times will be in form and substance reasonably acceptable to the Placement Agent, the Company
and their respective counsel, and shall contain such legends and other information as the Placement Agent, the Company and their
respective counsel may, from time to time, deem necessary and desirable to be set forth therein. The term “Memorandum”
as used in this Agreement means the Company’s Confidential Private Placement Memorandum dated September 8, 2011, inclusive
of all annexes, supplements and appendices thereto, if any. Unless otherwise defined, each capitalized term used in this Agreement
has the same meaning ascribed to it in the Memorandum.

 

2. Representations,
Warranties and Covenants of the Company. The Company hereby represents, warrants and covenants to the Placement Agent that
each of the following is true in all respects as of the date hereof:

 

(a) The Memorandum
has been diligently prepared by the Company, at its sole cost, in conformity with all applicable laws, and is in compliance with
Regulation D, the 1933 Act and the requirements of all other rules and regulations (the “Regulations”) of the
Securities and Exchange Commission (the “SEC”) relating to offerings of the type contemplated by the Offering,
and the applicable securities laws and the rules and regulations of those jurisdictions wherein the Units are to be offered and
sold excluding any foreign jurisdictions. The Units will be offered and sold pursuant to the registration exemption provided by
Regulation D and Section 4(2) of the 1933 Act as a transaction not involving a public offering and the requirements of any other
applicable state securities laws and the respective rules and regulations thereunder in those United States jurisdictions in which
the Placement Agent notifies the Company that the Units are being offered for sale. The Memorandum describes in all material
aspects, including attendant risks, of an investment in the Company. The Company has not taken nor will it take any action that
conflicts with the conditions and requirements of, or that would make unavailable with respect to the Offering, the exemption(s)
from registration available pursuant to Regulation D or Section 4(2) of the 1933 Act and knows of no reason why such exemption
would be otherwise unavailable to it. Neither the Company, nor, to the Company’s knowledge, any
person acting on its behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation
D) in connection with the offer or sale of the Units. None of the Company, its predecessors or affiliates, to the Company’s
knowledge, has been subject to any order, judgment or decree of any court or governmental authority of competent jurisdiction temporarily,
preliminarily or permanently enjoining such person for failing to comply with Section 503 of Regulation D, or any other applicable
state or federal securities laws. None of the Company, any of its affiliates, or any person acting on
its behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under
circumstances that would cause the offering of the Units to be integrated with prior offerings by the Company for purposes of the
1933 Act.  None of the Company, its affiliates or any person acting on its behalf will take any action or steps referred to
in the preceding sentence that would cause the offering of the Units to be integrated with other offerings.

 

    	2

    	 

    
 

 

(b) The Memorandum
does not include any untrue statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; provided,
however, the foregoing does not apply to any statements or omissions made solely in reliance on and in conformity with written
information furnished to the Company by the Placement Agent specifically for use in the preparation thereof. None of the statements,
documents, certificates or other items prepared or supplied by the Company with respect to the transactions contemplated hereby
contains an untrue statement of a material fact or omits to state a material fact necessary to make the statements contained therein
not misleading in light of the circumstances in which they were made. To its knowledge, the Company is not aware of any fact which
it has not disclosed in the Memorandum and to the Placement Agent and its counsel in writing that would materially adversely affect
or could reasonably be expected to have a material adverse effect on the prospects, condition (financial or otherwise), operations
or assets of the Company.

 

(c) The
Company is duly organized and validly existing in good standing under the laws of the state of Delaware, and has the requisite
power and authority to own its properties and to carry on its business as now being conducted.  The Company is duly qualified
as a foreign entity to do business and is in good standing in every jurisdiction in which its ownership of property or the nature
of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or
be in good standing would not have a Material Adverse Effect.  As used in this Agreement, “Material Adverse Effect”
means any material adverse effect on the business, properties, assets, operations, results of operations, condition (financial
or otherwise) or prospects (as the same are described in the Memorandum) of the Company, or on the transactions contemplated hereby
and the other Transaction Documents (as hereinafter defined) or by the agreements and instruments to be entered into in connection
herewith or therewith, or on the authority or ability of the Company to perform its obligations under the Transaction Documents
(as hereinafter defined), except an effect that results from general conditions affecting the U.S. economy or the world
economy. 

 

(d) The Company
has all corporate power and authority to (i) enter into and perform its obligations under this Agreement, the Subscription Agreement
substantially in the form of Annex A to the Memorandum (the “Subscription Agreement”), the Investor Rights Agreement
substantially in the form of Annex B to the Memorandum (the “Investor Rights Agreement”) and the other agreements
contemplated hereby (this Agreement, the Subscription Agreement, the Investor Rights Agreement and the other agreements contemplated
hereby, are collectively referred to herein as the “Transaction Documents”), (ii) issue, sell and deliver the
Shares, the Warrants and the Agent’s Warrants (as hereinafter defined), and (iii) issue, sell and deliver the shares of Common
Stock issuable upon exercise of the Warrants and the Agent’s Warrants (the “Warrant Shares”). The
execution and delivery of this Agreement and the other Transaction Documents by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby, have been duly authorized by the Company's Board of Directors. This
Agreement has been duly authorized, executed and delivered and constitutes, and each of the other Transaction Documents, upon due
execution and delivery, will constitute, valid and binding obligations of the Company, enforceable against the Company in accordance
with their respective terms (i) except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium
or other similar laws now or hereafter in effect related to laws affecting creditors’ rights generally, including the effect
of statutory and other laws regarding fraudulent conveyances and preferential transfers, and except that no representation is made
herein regarding the enforceability of the Company’s obligations to provide indemnification and contribution remedies under
the securities laws and (ii) subject to the limitations imposed by general equitable principles (regardless of whether such enforceability
is considered in a proceeding at law or in equity). The Company presently has no subsidiaries (which
for purposes of this Agreement means any joint venture or any entity in which the Company, directly or indirectly, owns capital
stock or holds an equity or similar interest).

 

    	3

    	 

    
 

 

(e) None of the
execution and delivery of, or performance by the Company under this Agreement or any of the other Transaction Documents or the
consummation of the transactions herein or therein contemplated conflicts with or violates, or will result in the creation or imposition
of, any lien, charge or other encumbrance upon any of the assets of the Company under any agreement or other instrument to which
the Company is a party or by which the Company or its assets may be bound, or any term of the certificate of incorporation or by-laws
of the Company, or any license, permit, judgment, decree, order, statute, rule or regulation applicable to the Company or any of
its assets.

 

(f) As of the date
of the First Closing (as hereinafter defined), the Company will have the authorized and outstanding capital stock as set forth
in the Memorandum. All outstanding shares of capital stock of the Company are duly authorized, validly issued and outstanding,
fully paid and nonassessable. Except as described in the Memorandum or provided for in the Transaction Documents, as of the date
of the First Closing: (i) there will be no outstanding options, stock subscription agreements, warrants or other rights permitting
or requiring the Company or others to purchase or acquire any shares of capital stock or other equity securities of the Company
or to pay any dividend or make any other distribution in respect thereof; (ii) there will be no securities issued or outstanding
which are convertible into or exchangeable for any of the foregoing and there are no contracts, commitments or understandings,
whether or not in writing, to issue or grant any such option, warrant, right or convertible or exchangeable security; (iii) no
shares of stock or other securities of the Company are reserved for issuance for any purpose; (iv) there will be no voting trusts
or other contracts, commitments, understandings, arrangements or restrictions of any kind with respect to the ownership, voting
or transfer of shares of stock or other securities of the Company, including without limitation, any preemptive rights, rights
of first refusal, proxies or similar rights, and (v) no person holds a right to require the Company to register any securities
of the Company under the Act or to participate in any such registration. As of the date of the First Closing, the issued and outstanding
shares of capital stock of the Company will conform to all statements in relation thereto contained in the Memorandum and the Memorandum
describes all material terms and conditions thereof. All issuances by the Company of its securities have been, at the times
of their issuance, exempt from registration under the 1933 Act and any applicable state securities laws.

 

(g) Immediately
prior to the First Closing, the Shares, the Warrants, the Agent’s Warrants and the Warrant Shares will have been duly authorized
and, when issued and delivered against payment therefor as provided in the Transaction Documents, will be validly issued, fully
paid and nonassessable. No holder of the Shares, the Warrants, the Agent’s Warrants, or the Warrant Shares will be subject
to personal liability solely by reason of being such a holder, and except as described in the Memorandum, none of the Shares, the
Warrants, the Agent’s Warrants, or the Warrant Shares are subject to preemptive or similar rights of any stockholder or security
holder of the Company or an adjustment under the antidilution or exercise rights of any holders of any outstanding shares of capital
stock, options, warrants or other rights to acquire any securities of the Company. Immediately prior to the First Closing, a sufficient
number of authorized but unissued shares of Common Stock to be issued upon exercise of the Warrants and the Agent’s Warrants
will have been reserved for issuance.

 

    	4

    	 

    
 

 

(h) No consent,
authorization or filing of or with any court or governmental authority is required in connection with the issuance or the consummation
of the transactions contemplated herein or in the other Transaction Documents, except for required filings with the SEC and applicable
state securities commissions relating specifically to the Offering (all of which filings will be duly made by, or on behalf of,
the Company), other than those which are required to be made after the First Closing (all of which will be duly made on a timely
basis).

 

(i) Except as set
forth in the Memorandum, the Company has no known material liabilities of any kind, whether accrued, absolute or contingent, or
otherwise, and subsequent to the date of the Memorandum it shall not enter into any material transactions or commitments without
promptly thereafter notifying the Placement Agent in writing of any such material transaction or commitment. Any pro forma financial
information and related notes included in the Memorandum present fairly the information based on the Company’s management’s
prudent business judgment. The Company does not know of any facts, circumstances or conditions which could materially adversely
affect its operations, earnings or prospects that have not been fully disclosed in the Memorandum.

 

(j) The conduct
of business by the Company as presently and proposed to be conducted is not subject to continuing oversight, supervision, regulation
or examination by any governmental official or body of the United States, or any other jurisdiction wherein the Company conducts
or proposes to conduct such business, except as described in the Memorandum and except as such regulation is applicable to commercial
enterprises generally.

 

(k) Except
as set forth in the Memorandum, the Company (i) does not have any outstanding Indebtedness (as hereinafter defined), (ii) is not
a party to any contract, agreement or instrument, the violation of which, or default under which, by the other party(ies) to such
contract, agreement or instrument would result in a Material Adverse Effect, (iii) is not in violation of any term of or in default
under any contract, agreement or instrument relating to any Indebtedness, except where such violations and defaults would not result,
individually or in the aggregate, in a Material Adverse Effect, or (iv) is not a party to any contract, agreement or instrument
relating to any Indebtedness, the performance of which, in the judgment of the Company's officers, has or is expected to have a
Material Adverse Effect. For purposes of this Agreement: (x) “Indebtedness” of any Person means, without duplication
(A) all indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed as the deferred purchase price of property
or services including (without limitation) “Capital Leases” in accordance with generally accepted accounting principles
(other than trade payables entered into in the ordinary course of business), (C) all reimbursement or payment obligations with
respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures
or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses,
(E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing,
in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights and
remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale of such property),
(F) all monetary obligations under any leasing or similar arrangement which, in connection with generally accepted accounting principles,
consistently applied for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses
(A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise,
to be secured by) any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets
(including accounts and contract rights) owned by any Person, even though the Person which owns such assets or property has not
assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect of indebtedness or
obligations of others of the kinds referred to in clauses (A) through (G) above; (y) “Contingent Obligation”
means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to any indebtedness,
lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability,
or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or discharged,
or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole
or in part) against loss with respect thereto; and (z) “Person” means an individual, a limited liability company,
a partnership, a joint venture, a corporation, a trust, an unincorporated organization and a government or any department or agency
thereof.

 

    	5

    	 

    
 

 

(l) No default
by the Company or, to the best knowledge of the Company, any other party, exists in the due performance under any material agreement
to which the Company is a party or to which any of its assets is subject (collectively, the “Company Agreements”).
The Company Agreements disclosed in the Memorandum are the only material agreements to which the Company is bound or by which its
assets are subject, are accurately described in the Memorandum and are in full force and effect in accordance with their respective
terms, subject to any applicable bankruptcy, insolvency or other laws affecting the rights of creditors generally and to general
equitable principles and the availability of specific performance.

 

(m) There is no
action, suit, proceeding, claim or investigation, before or by any court, public board, governmental agency, self regulatory organization
or body (or any state of facts which management of the Company has concluded could give rise thereto) pending or, to the knowledge
of the Company, threatened, against the Company, or involving any of its assets, or involving any of its officers or directors.

 

(n) The execution,
delivery and performance of this Agreement and the Transaction Documents by the Company as well as the
consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of
the Shares, the Warrants and the Agent’s Warrants and reservation for issuance of the underlying Common Stock) will not result
in a violation of: (i) the certificate of incorporation or by-laws, each as may be amended, of the Company; (ii) any indenture,
mortgage, deed of trust, note or other agreement or instrument to which the Company is a party or may be bound, or to which any
of its assets may be subject; (iii) any statute, rule or regulation currently applicable to the Company, or (iv) any judgment,
decree or order applicable to the Company, which violation or violations individually, or in the aggregate, and could reasonably
be expected to result in any Material Adverse Effect.

 

    	6

    	 

    
 

 

(o) The Company
does not own any real property in fee simple, and the Company has good and marketable title to all property (personal, tangible
and intangible) owned by the Company, free and clear of all security interests, liens and encumbrances, except for such as are
described in the Memorandum.

 

(p) As of the First
Closing, the Company will own all right, title and interest in, or possesses adequate and enforceable rights to use, all patents,
patent applications, trademarks, service marks, copyrights, rights, licenses, franchises, trade secrets, confidential information,
processes and formulations necessary for the conduct of its businesses as described in the Memorandum (collectively, the “Intangibles”).
To its knowledge, the Company does not infringe upon the rights of others with respect to the Intangibles and has not received
notice that it has or may have infringed or is infringing upon the rights of others with respect to the Intangibles, or any notice
of conflict with the asserted rights of others with respect to the Intangibles. To the Company’s knowledge, no others have
infringed upon the rights of the Company with respect to the Intangibles. Except as set forth in the
Memorandum, none of the Company's Intangibles have expired or terminated, or are expected to expire or terminate, within three
years from the date of this Agreement.  

 

(q)  The Company
is not a party to any collective bargaining agreement and does not employ any member of a union. No executive officer of the Company
(as defined in Rule 501(f) of the 1933 Act) has notified the Company that such officer intends to leave the Company or otherwise
terminate such officer's employment with the Company.

 

(r) Subsequent
to the respective dates as of which information is given in the Memorandum, and except as would not have a Material Adverse Effect,
the Company has operated its business in the ordinary course and, except as may otherwise be set forth in the Memorandum, there
has been no: (i) material adverse change in the condition (financial or otherwise) of the Company; (ii) transaction otherwise
than in the ordinary course of business consistent with past practice; (iii) issuance of any securities (debt or equity) or
any rights to acquire any such securities; (iv) damage, loss or destruction, whether or not covered by insurance, with respect
to any asset or property of the Company; or (v) agreement to permit any of the foregoing.

 

(s) The Company
is not obligated to pay, and has not obligated the Placement Agent to pay, a finder’s or origination fee in connection with
the Offering, and hereby agrees to indemnify the Placement Agent from any such claim made by any other person as more fully set
forth in Section 8 hereof. Except as set forth in the Memorandum, the Company has not offered for sale or solicited offers to purchase
the Units except for negotiations with the Placement Agent. Except as set forth in the Memorandum, no other person has any right
to participate in any offer, sale or distribution of the Company’s securities to which the Placement Agent’s rights,
described herein, shall apply.

 

    	7

    	 

    
 

 

(t) Except
as set forth in the Memorandum, none of the officers, directors or employees of the Company is presently a party to any transaction
with the Company (other than for ordinary course services as employees, officers or directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or
from, or otherwise requiring payments to or from any such officer, director or employee or any corporation, partnership, trust
or other entity in which any such officer, director, or employee has a substantial interest or is an officer, director, trustee
or partner.

 

(u) Neither the
Company nor any director, officer, agent, employee or other Person acting on behalf of the Company, to its knowledge, has, in the
course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift, entertainment
or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or
domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign
Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other
unlawful payment to any foreign or domestic government official or employee.

 

(v) Neither the
sale of the Units by the Company nor its use of the proceeds thereof will violate the Trading with the Enemy Act, as amended, or
any of the foreign assets control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter V, as amended)
or any enabling legislation or executive order relating thereto. Without limiting the foregoing, the Company is not (a) a person
whose property or interests in property are blocked pursuant to Section 1 of Executive Order 13224 of September 23, 2001 Blocking
Property and Prohibiting Transactions with Persons Who Commit, Threaten to Commit, or Support Terrorism (66 Fed. Reg. 49079 (2001))
or (b) a person who engages in any dealings or transactions, or be otherwise associated, with any such person. The Company is in
compliance, in all material respects, with the USA Patriot Act of 2001 (signed into law October 26, 2001).

 

(w) There is no
transaction, arrangement, or other relationship between the Company and an unconsolidated or other off-balance sheet entity that
is not disclosed in the Memorandum or that otherwise would be reasonably likely to have a Material Averse Effect.

 

3. Representations,
Warranties and Covenants of the Placement Agent. The Placement Agent represents, warrants and covenants to the Company, that:

 

(a) This Agreement
has been duly authorized, executed and delivered by the Placement Agent and constitutes the legal, valid and binding obligation
of the Placement Agent, enforceable against the Placement Agent in accordance with its terms (i) except as enforceability may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws now or hereafter in effect related
to laws affecting creditors’ rights generally, including the effect of statutory and other laws regarding fraudulent conveyances
and preferential transfers, and except that no representation is made herein regarding the enforceability of the Placement Agent’s
obligations to provide indemnification and contribution remedies under the securities laws and (ii) subject to the limitations
imposed by general equitable principles (regardless of whether such enforceability is considered in a proceeding at law or in equity).

 

    	8

    	 

    
 

 

(b) It is, and
on the date of each Closing shall be (i) a broker-dealer registered under the U.S. Securities Exchange Act of 1934, as amended
(the “1934 Act”) with the SEC, (ii) a member in good standing of the Financial Industry Regulatory Authority,
Inc., (iii) registered as a broker-dealer and be a member in good standing in each jurisdiction in which it is required to be registered
in order to offer and sell the Units or to perform the services described in this Agreement in such jurisdiction.

 

(c) It acknowledges
that the Units have not been registered under the 1933 Act and may be offered and sold only in transactions exempt form or not
subject to the registration requirements of the 1933 Act.

 

(d) It has not
offered or sold, and will not offer or sell, any Units except in compliance with Section 3(e) through (g) below.

 

(e) Offers and
sales of the Units by it have not been and shall not be made: (i) by any form of general solicitation or general advertising (as
those terms are used in Regulation D), including advertisements, articles, notices or other communications published in any newspaper,
magazine, or similar media or broadcast over radio or television, or any seminar or meeting whose attendees had been invited by
general solicitation or general advertising or (ii) in any manner involving a public offering within the meaning of Section 4(2)
of the 1933 Act.

 

(f) Any offer or
solicitation of an offer to buy the Units that has been made or will be made only to investors that the Placement Agent believes
to be “accredited investors” (as defined in Regulation D) and sales will only be made to “accredited investors”
pursuant to a Subscription Agreement.

 

(g) The Placement
Agent has not made and will not make an offer of the Units on the basis of any communications or documents relating to the Company
or the Units except the Memorandum, and an investor Power Point presentation and executive overview approved by the Company (collectively,
the “Investor Presentation”). Without limiting the generality of the foregoing, the Placement Agent has not
made and will not make any representation as to any rate of return on investment that an investor may obtain from the ownership
of the Units, other than that as set forth in the Memorandum. The Placement Agent has delivered or will deliver a copy of the Memorandum
(and any amendments and supplements thereto) to each prospective investor solicited by it prior to such investor’s execution
of the applicable Transaction Documents.

 

(h) Any contents
of the Memorandum provided to the Company in writing (including by e-mail) by the Placement Agent specifically for inclusion in
the Memorandum or the Investor Presentation are based on or derived from sources that the Placement Agent believes to be reliable
and accurate.

 

    	9

    	 

    
 

 

4. Placement
Agent Appointment and Compensation.

 

(a)The Company
hereby appoints the Placement Agent and its selected dealers, if any, as its exclusive agent in connection with the Offering. The
Company has not and will not make, or permit to be made, any offers or sales of the Units other than through the Placement Agent
without the Placement Agent’s prior written consent. The Placement Agent has no obligation to purchase any of the Units.
The agency of the Placement Agent hereunder shall continue until the later of the Termination Date and the Final Closing.

 

(b) The Company
will cause to be delivered to the Placement Agent copies of the Memorandum and has consented, and hereby consents, to the use of
such copies for the purposes permitted by the 1933 Act and applicable securities laws, and hereby authorizes the Placement Agent
and its agents, employees and selected dealers to use the Memorandum in connection with the sale of the Units until the earlier
of the Final Closing and the Termination Date, and no other person or entity is or will be authorized to give any information or
make any representations other than those contained in the Memorandum or to use any offering materials other than those contained
in the Memorandum in connection with the sale of the Units.

 

(c) The Company
will cooperate with the Placement Agent by making available to its representatives such information as may be reasonably requested
in making a reasonable investigation of the Company and its affairs and shall provide access to such employees as shall be reasonably
requested. Prior to the First Closing, if requested by the Placement Agent, the Company shall provide, at its own expense, credit
or similar reports on such key management persons as the Placement Agent shall reasonably request.

 

(d) In connection
with the Offering, the Company will pay a cash fee (the “Agent’s Fee”) to the Placement Agent at each
Closing equal to 10% of the aggregate gross proceeds from the sale of Units sold in the Offering.

 

(e) As additional
compensation hereunder, at each Closing the Company will issue to the Placement Agent or its designees, for nominal consideration,
warrants to purchase 20% of (i) the shares of Common Stock sold in the Offering at an exercise price of $1.00 per share; and (ii)
the shares of Common Stock underlying the Warrants sold in the Offering at an exercise price of $1.50 per share (collectively,
the “Agent’s Warrants”). The Agent’s Warrants and the Agent’s Fee are sometimes collectively
referred to herein as the “Agent’s Compensation.” The holders of Agent’s Warrants shall be entitled
to registration rights with respect to the shares of Common Stock underlying the Agent’s Warrants on the same terms as those
to be granted to the investors in the Offering as provided for in the Investor Rights Agreement. The Agent’s Warrants shall
contain the same provisions as the Warrants but shall also contain a cashless exercise right.

 

(f) The Placement
Agent shall also receive a non-accountable expense allowance equal to three percent (3%) of the gross proceeds raised at each Closing
(the “Agent Expense Allowance”), which shall cover all of the costs and expenses of the Placement Agent including
legal fees of Placement Agent’s counsel (excluding Blue Sky Expenses (as defined in Section 6(j) below), travel costs, due
diligence costs, marketing expenses including expenses related to Company presentations. Payment of the Agent Expense Allowance
will be made out of the proceeds of Units sold at each Closing.

 

    	10

    	 

    
 

 

(g) The Company
shall also pay and issue to the Placement Agent the Agent’s Compensation calculated according to the percentages set forth
in Sections 4(d) and (e) of this Agreement, if any person or entity contacted by the Placement Agent with respect to the Offering
during the Offering Period, (the “Post-Closing Investors”), invests in the Company at any time prior to the
date that is two (2) years from the later of the Termination Date or the Final Closing (as defined below), regardless of whether
such Post-Closing Investor purchased Units in the Offering. If such an event or transaction occurs, the Placement Agent is entitled
to receive the Agent’s Compensation. For clarification purposes, Post-Closing Investors shall exclude executive officers
and directors of the Company. No fees (including the Agent’s Compensation) pursuant to this Section 4(g) shall be paid to
the Placement Agent with respect to investments made as part of any registered public offering of the Company’s securities.

 

(h) At the First
Closing, the Company and the Placement Agent shall enter into a non-exclusive Finder’s Fee Agreement (the “Finder’s
Agreement”), which will provide that if the Company or any of its affiliates shall enter into any of the transactions
enumerated in the Finder’s Agreement (which shall include financing transactions and business combinations or similar arrangements
with the Company, including, without limitation, a merger, the purchase of some or all of the stock or assets of the Company, or
an investment in the securities of the Company) with any party introduced to the Company by the Placement Agent, directly or indirectly
at any time prior to the date which is four (4) years after the later of the Termination Date and the Final Closing, then the Company
shall pay or cause to be paid to the Placement Agent a cash finder’s fee (the “Finder’s Fee”) according
to the following table:

 

		(i)	7% of the first $1,000,000 or portion thereof of the consideration paid in such transaction; plus

		(ii)	6% of the next $1,000,000 or portion thereof of the consideration paid in such transaction; plus

		(iii)	5% of the next $5,000,000 or portion thereof of the consideration paid in such transaction; plus

		(iv)	4% of the next $1,000,000 or portion thereof of the consideration paid in such transaction; plus

		(v)	3% of the next $1,000,000 or portion thereof of the consideration paid in such transaction; plus

		(vi)	2.5% of any consideration paid in such transaction in excess of $9,000,000.

 

Any such Finder’s Fee due shall be
paid at the closing of the particular consummated transaction for which the Finder’s Fee is payable. In addition, to avoid
any doubt, if Finder’s Fee is paid pursuant to 4(h), the Placement Agent shall not be also be entitled to receive any Agent’s
Compensation pursuant to Section 4(g). Notwithstanding the foregoing, however, no Finder’s Fee shall be payable in respect
of an investment in the Company by the Placement Agent and/or its related parties or affiliates.

 

    	11

    	 

    
 

 

(i)At the First
Closing, the Company and the Placement Agent shall enter into a Right of First Refusal Agreement (the “ROFR Agreement”)
in a form acceptable to the Company and the Placement Agent and their respective counsel. The ROFR Agreement shall provide that,
for a period of two (2) years from the Final Closing, the Company shall give the Placement Agent the irrevocable preferential right
of first refusal described below to purchase for the Placement Agent’s account or to act as agent for any proposed private
offering of securities (equity or debt) by the Company. The Company agrees to offer the Placement Agent the opportunity to purchase
or sell such securities on terms no less favorable than it can obtain elsewhere. If, within ten (10) days of the receipt of such
notice of intention and statement of terms, the Placement Agent does not accept in writing such offer to purchase such securities
or to act as agent with respect to such offering upon the terms proposed, the Company shall be free to negotiate terms with third
parties with respect to such offering and to effect such offering on such proposed terms. Before the Company shall accept any proposal
materially less favorable to it than as originally proposed to the Placement Agent, the Placement Agent’s preferential rights
shall be applied, and the procedure set forth above with respect to such modified proposal shall be adopted. The Placement Agent’s
failure to exercise these preferential rights in any situation shall not affect the Placement Agent’s preferential rights
to any subsequent offering during the term of the ROFR Agreement. The Company represents and warrants that no other person has
any right to participate in any offer, sale or distribution of the Company’s securities to which the Placement Agent’s
preferential rights shall apply.

 

(j) For a period
of two (2) years from the First Closing, the Company hereby grants the Placement Agent the right to appoint one (1) member of the
Company’s board of directors (the “STV Director”). The initial STV Director shall be Adam Stern, who shall
be appointed to the Board of Directors at the First Closing, with any successor STV Director chosen by the Placement Agent to be
subject to the reasonable approval of the Company. The STV Director shall be entitled to the same indemnification and director
compensation (if any) as any other director of the Company and shall be subject to removal on the same terms as any other director
of the Company.

 

5. Subscription
and Closing Procedures.

 

(a) Each prospective
subscriber will be required to complete and execute an original omnibus signature page, for each of the Subscription Agreement
and Investor Rights Agreement (collectively referred to herein as the “Subscription Documents”), which
will be forwarded or delivered to the Placement Agent at the Placement Agent’s offices at the address set forth in Section
12 hereof, together with the subscriber’s check or other good funds in the full amount of the Offering Price for the number
of Units desired to be purchased.

 

(b) All funds for
subscriptions received from the Offering will be promptly forwarded by the Placement Agent or the Company, if received by it, to,
and deposited into, a non-interest bearing escrow account (the “Escrow Account”) established for such purpose
with Signature Bank (the “Escrow Agent”). All such funds for subscriptions will be held in the Escrow Account
pursuant to the terms of an escrow agreement among the Company, the Placement Agent and the Escrow Agent. The Company will pay
all fees related to the establishment and maintenance of the Escrow Account. Subject to the receipt of subscriptions for the Minimum
Amount, the Company will either accept or reject, for any or no reason, the Subscription Documents in a timely fashion and at each
Closing will countersign the Subscription Documents and provide duplicate copies of such documents to the Placement Agent for distribution
to the subscribers. The Company will give notice to the Placement Agent of its acceptance of each subscription. The Company, or
the Placement Agent on the Company’s behalf, will promptly return to subscribers incomplete, improperly completed, improperly
executed and rejected subscriptions and give written notice thereof to the Placement Agent upon such return.

 

    	12

    	 

    
 

 

(c) If subscriptions
for at least the Minimum Amount have been accepted prior to the Termination Date, the funds therefor have been collected by the
Escrow Agent and all of the conditions set forth elsewhere in this Agreement are fulfilled, a closing shall be held promptly with
respect to Units sold (the “First Closing”). Thereafter, the remaining Units will continue to be offered and
sold until the Termination Date. Additional closings (“Closings,” each closing, collectively with the First
Closing, “Closing”) may from time to time be conducted at times mutually agreed to between the Placement Agent
and the Company with respect to additional Units sold, with the final closing (“Final Closing”) to occur within
10 days after the earlier of the Termination Date and the date on which the Maximum Amount has been subscribed for. Delivery of
payment for the accepted subscriptions for Units from the funds held in the Escrow Account will be made at each Closing at the
Placement Agent’s offices against delivery of the Units by the Company at the address set forth in Section 12 hereof
(or at such other place as may be mutually agreed upon between the Company and the Placement Agent), net of amounts due to the
Placement Agent and its Blue Sky counsel as of such Closing. Executed instruments/certificates for the shares of Common Stock and
Warrants constituting the Units and the Agent’s Warrants will be in such authorized denominations and registered in such
names as the Placement Agent may request on or before the date of each Closing (“Closing Date”), and will be
made available to the Placement Agent for checking and packaging at the Placement Agent’s office at each Closing. 

 

(d)If Subscription
Documents for the Minimum Amount have not been received and accepted by the Company on or before the Termination Date for any reason,
the Offering will be terminated, no Units will be sold, and the Escrow Agent will, at the request of the Placement Agent or the
Company, cause all monies received from subscribers for the Units to be promptly returned to such subscribers without interest,
penalty, expense or deduction.

 

6. Further Covenants
of the Company. The Company hereby covenants and agrees that:

 

(a) Except with
prior written notice to the Placement Agent, the Company shall not, at any time prior to the Final Closing, take any action which
would cause any of the representations, warranties and covenants made by it in this Agreement not to be complete, accurate and
correct in all material respects on and as of each Closing Date with the same force and effect as if such representations, warranties
and covenants had been made on and as of each such date.

 

(b) If, at any
time prior to the Final Closing (i) any event shall occur which does or may materially affect the Company or as a result of which
it might become necessary to amend or supplement the Memorandum so that the representations, warranties and covenants herein remain
true, or (ii) in case it shall, in the reasonable opinion of counsel to the Placement Agent, be necessary to amend or supplement
the Memorandum to comply with Regulation D or any other applicable securities laws or regulations, the Company shall, in the case
of (i) above, promptly notify the Placement Agent and, in the event of either (i) or (ii) above shall, at its sole cost, prepare
and furnish to the Placement Agent copies of appropriate amendments and/or supplements to the Memorandum in such quantities as
the Placement Agent may request. The Company shall not at any time, whether before or after the Final Closing, prepare or use any
supplement to the Memorandum of which the Placement Agent shall not previously have been advised and furnished with a copy, or
to which the Placement Agent or its counsel will have reasonably objected in writing or orally (confirmed in writing within 24
hours), or which is not in compliance in all material respects with the 1933 Act, the Regulations and other applicable securities
laws. As soon as the Company is advised thereof, the Company shall advise the Placement Agent and its counsel, and confirm the
advice in writing, of any order preventing or suspending the use of the Memorandum, or the suspension of the qualification or registration
of the Units for offering or the suspension of any exemption for such qualification or registration of the Units for offering in
any jurisdiction, or of the institution or threatened institution of any proceedings for any of such purposes, and the Company
shall use its best efforts to prevent the issuance of any such order and, if issued, to obtain as soon as reasonably possible the
lifting thereof.

 

    	13

    	 

    
 

 

(c) The Company
shall comply with the 1933 Act, the Regulations, the 1934 Act, and the rules and regulations promulgated thereunder, all applicable
state securities laws and the rules and regulations thereunder in the states in which the Units are to be offered and in which
Blue Sky counsel has advised the Placement Agent that the Units are exempt from qualification or registration requirements, so
as to permit the continuance of the sales of the Units, and will file with the SEC, and shall promptly thereafter forward to the
Placement Agent, any and all reports on Form D as are required.

 

(d) The Company
shall use its reasonable best efforts to qualify the Units for sale under the securities laws of such jurisdictions in the United
States as may be mutually agreed to by the Company and the Placement Agent, and the Company will make such applications and furnish
information as may be required for such purposes; provided, however, that the Company shall not be required to qualify as
a foreign corporation in any jurisdiction. The Company shall, from time to time, prepare and file such statements and reports as
are or may be required to continue such qualifications in effect for so long a period as the Placement Agent may reasonably request.
Furthermore, the Company shall file a copy of a Notice of Sale on Form D with the SEC within the prescribed time period and shall
file all amendments with the SEC as may be required. Copies of the Form D and all amendments thereto shall be provided promptly
to the Placement Agent.

 

(e) The Company
shall place a legend on the certificates representing the Shares and the Warrants issued to subscribers stating that the securities
evidenced thereby have not been registered under the 1933 Act or applicable state securities laws and setting forth or referring
to the applicable restrictions on transferability and sale of such securities under the 1933 Act and applicable state laws.

 

    	14

    	 

    
 

 

(f) The Company
shall apply the net proceeds from the sale of the Units to fund its working capital requirements and for such other purposes as
are specifically described under the “Use of Proceeds” section of the Memorandum. Except as set forth in the Memorandum,
the Company shall not use any of the net proceeds of the Offering to repay indebtedness to officers, directors or stockholders
of the Company without the prior written consent of the Placement Agent.

 

(g) During the
Offering Period, the Company shall make available for review by prospective subscribers for Units during normal business hours
at the Company’s offices, upon their reasonable request, copies of the Company Agreements to the extent that such shall not
violate any obligation on the part of the Company to maintain the confidentiality thereof and shall afford each prospective subscriber
for Units the opportunity to ask questions of and receive answers from an officer of the Company concerning the terms and conditions
of the Offering and the opportunity to obtain such other additional information necessary to verify the accuracy of the Memorandum
to the extent it possesses such information or can acquire it without unreasonable expense or effort.

 

(h) Except with
the prior written consent of the Placement Agent, the Company shall not, at any time prior to the earlier of the Final Closing
or the Termination Date, (i) engage in or commit to engage in any transaction outside the ordinary course of business as described
in the Memorandum, (ii) issue, agree to issue or set aside for issuance any securities (debt or equity) or any rights to acquire
any such securities except as contemplated by the Memorandum, (iii) incur, outside the ordinary course of business, any material
indebtedness, (iv) dispose of any material assets, (v) make any material acquisition or (vi) change its business or operations.

 

(i) Until completion
at the earlier of (a) the effectiveness of the Resale Registration Statement or (b) the consummation of an underwritten initial
public offering of the Company’s Common Stock, the Company shall deliver to the Placement Agent and the Company’s stockholders:
(i) annual unaudited financial statements setting forth fairly the financial position of the Company; (ii) quarterly
unaudited financial statements including both a balance sheet and statement of income (with year over year quarterly comparisons);
and (iii) a quarterly report of the progress and status of the Company and an annual report setting forth clearly the financial
position and outlook of the Company; provided, however, that such report need not contain information reasonably deemed
confidential by the Company’s Board of Directors. In addition, the Company shall deliver to the Placement Agent such quarterly
unaudited financial statements as are prepared for the Company’s Board of Directors and a copy of a list of its stockholders
as and when so requested, (only for use in connection with the Company) and shall establish and maintain a Company website for
the dissemination of general Company information.

 

(j) The Company
shall pay all expenses incurred in connection with the preparation and printing of all necessary offering documents, amendments,
and instruments related to the Offering and the issuance of the Units, the Shares, the Warrants, and the Agent’s Warrants,
and shall also pay its own expenses for accounting fees, legal fees, bound volumes of closing documents, and other costs involved
with the Offering. The Company shall provide at its own expense such quantities of the Memorandum and other documents and instruments
relating to the Offering as the Placement Agent may reasonably request. In addition, the Company shall pay for all Blue Sky Expenses
(as defined below) relating to the preparation and filing of state Blue Sky exemptions that are sought with respect to the Offering.
As used herein, the term “Blue Sky Expenses” means solely an amount equal to $750 per state for legal fees,
plus an additional amount commensurate with the required state filing fees. The amount of the Blue Sky Fees shall be paid to the
Placement Agent’s counsel each Closing. The Blue Sky filings shall be prepared by the Placement Agent’s counsel for
the Company’s account. The Placement Agent shall cause such counsel to make such filings on a timely basis in accordance
with applicable law.

 

    	15

    	 

    
 

 

(k) Until the earlier
of (i) the Final Closing, and (ii) the Termination Date, neither the Company nor any person or entity acting on its behalf shall
negotiate with any other placement agent or underwriter with respect to a private or public offering of the Company’s or
any affiliate’s debt or equity securities. Neither the Company nor anyone acting on its behalf shall, until the earlier of
the Final Closing or the Termination Date, offer for sale to, or solicit offers to subscribe for Units or other securities of the
Company from, or otherwise approach or negotiate in respect thereof with, any other person, without the prior written consent of
the Placement Agent.

 

(l) Until the later
of (i) the Termination Date and (ii) the Final Closing, the Company will not issue any press release, grant any interview, or otherwise
communicate with the media in any manner whatsoever without the Placement Agent’s prior written consent, which consent will
not unreasonably be withheld or delayed.

 

(m)Following the
Final Closing, the Company shall use its commercially reasonable best efforts to obtain insurance by
insurers of recognized financial responsibility against such losses and risks and in such amounts as management of the Company
believes to be prudent and customary in the businesses in which the Company is engaged. 

 

7. Conditions
of Placement Agent’s Obligations. The obligations of the Placement Agent hereunder are subject to the fulfillment, at
or before each Closing, of the following additional conditions:

 

(a) Each of the
representations and warranties of the Company qualified as to materiality shall be true and correct at all times prior to and on
each Closing Date, except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case
such representation or warranty shall be true and correct as of such earlier date, and the representations and warranties of the
Company not qualified as to materiality shall be true and correct in all material respects at all times prior to and on each Closing
Date, except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation
or warranty shall be true and correct in all material respects as of such earlier date.

 

(b) The Company
shall have performed and complied, in all material respects, with all agreements, covenants and conditions required to be performed
and complied with by it pursuant to this Agreement and under the Transaction Documents at or before each Closing.

 

(c) No order suspending
the use of the Memorandum or enjoining the offering or sale of the Units shall have been issued, and no proceedings for that purpose
or a similar purpose shall have been initiated or pending, or, to the best of the Company’s knowledge, are contemplated or
threatened.

 

    	16

    	 

    
 

 

(d) As of the First
Closing, the Company will have the authorized capitalization as described in the Memorandum.

 

(e) No judgment,
writ, order, injunction, award or decree of or by any court, or judge, justice or magistrate, including any bankruptcy court or
judge, or any order of or by any governmental authority, shall have been issued, and no action or proceeding shall have been instituted
by any governmental authority, enjoining or preventing the consummation of the transactions contemplated hereby or in the other
Transaction Documents.

 

(f) The Placement
Agent shall have received a certificate of the Chief Executive Officer of the Company, dated as of each Closing Date, certifying,
in such detail as the Placement Agent may reasonably request, as to the fulfillment of the conditions set forth in paragraphs (a),
(b), (c), (d) and (e) above.

 

(g) The Company
shall have delivered to the Placement Agent: (i) a currently dated good standing certificate from the Secretary of State of Delaware
and each jurisdiction in which the Company is qualified to do business as a foreign corporation and (ii) at the First Closing,
certified resolutions of the Company’s Board of Directors approving this Agreement and the other Transaction Documents, and
the transactions and agreements contemplated by this Agreement and the other Transaction Documents.

 

(h) At each Closing,
the Chief Executive Officer and the Chief Financial Officer of the Company shall have provided a certificate to the Placement Agent
confirming that, to their knowledge, there have been (i) no material adverse changes in the condition (financial or otherwise)
or prospects of the Company from the date of the financial statements included in the Memorandum, and (ii) no incurrence by the
Company of any undisclosed material liabilities (other than liabilities arising in the ordinary course of business subsequent to
the date of the most recent balance sheet included in the Memorandum) and such other matters relating to the financial condition
and prospects of the Company that the Placement Agent may reasonably request.

 

(i) At each Closing,
the Company shall pay and deliver to the Placement Agent the Agent’s Fee, calculated in accordance with Sections 4(d) and
the Blue Sky Expenses in accordance with Section 6(j) hereof.

 

(j) At each Closing,
the Company shall pay and deliver to the Placement Agent the Agent’s Expense Allowance, calculated in accordance with Section
4(f) hereof.

 

(k) At each Closing
(or at the Final Closing at the Placement Agent’s sole discretion), the Company shall have delivered to the Placement Agent
and/or its designees, the appropriate number of Agent’s Warrants, calculated in accordance with Section 4(e) hereof.

 

    	17

    	 

    
 

 

(l) Concurrently
with the formation of the Company, 6,500,000 shares of Common Stock shall have been issued to Strategic Models LLC, David Weintraub,
Shilo Ben Zeev, Meir Plevinsli, Dov Oppenheim, Irena and Eyal Cohen and Yaniv Michaeli (collectively, the “Founders”),
on a pro-rata basis, at price per share equal to the par value per share of the Common Stock. Concurrently with or immediately
prior to the consummation of the First Closing, the Founders shall contribute (pursuant to documentation acceptable to the Placement
Agent in its reasonable discretion) to the Company all intellectual property and their rights or assets necessary for the conduct
of the Company’s business as described in the Memorandum in consideration of the issuance of 1,000,000 additional shares
of Common Stock in a transaction (collectively with the investment made by the investors in the Offering) intended to qualify as
tax free under Section 351 of the Internal Revenue Code of 1986, as amended.

 

(m)At the First
Closing and each Closing thereafter, (i) the Company and each subscriber as of the date thereof shall have entered into a Subscription
Agreement and (ii) the Company, each subscriber as of the date thereof, and the Placement Agent shall have entered into the Investor
Rights Agreement. At each Closing following the First Closing, additional subscribers shall have entered into a Subscription Agreement
and an Investor Rights Agreement.

 

(n) At the First
Closing and each Closing thereafter (or within 3 business days following such Closing), the Company shall have executed and delivered
to the Placement Agent, on behalf of the subscribers, certificates for the Shares and Warrants in the respective amount set forth
opposite each of the subscribers set forth on a closing subscriber list spreadsheet for the relevant closing.

 

(o) There shall
have been delivered to the Placement Agent a signed opinion of counsel to the Company, dated as of each Closing Date, in form and
substance reasonably satisfactory to counsel to the Placement Agent.

 

(p) All proceedings
taken at or prior to each Closing in connection with the authorization, issuance and sale of the Units, the Shares, the Warrants,
the Agent’s Warrants and the Warrant Shares will be reasonably satisfactory in form and substance to the Placement Agent
and its counsel, and such counsel shall have been furnished with all such documents, certificates and opinions as it may reasonably
request upon reasonable prior notice in connection with the transactions contemplated hereby.

 

8. Indemnification.

 

(a) The Company
will (i) indemnify and hold harmless the Placement Agent, its selected dealers and their respective officers, directors, employees
and each person, if any, who controls the Placement Agent within the meaning of the 1933 Act and such selected dealers (each an
“Indemnitee”) against, and pay or reimburse each Indemnitee for, any and all losses, claims, damages, liabilities
or expenses whatsoever (or actions or proceedings or investigations in respect thereof), joint or several (which will, for all
purposes of this Agreement, include, but not be limited to, all reasonable costs of defense and investigation and all reasonable
attorneys’ fees and disbursements, including appeals), to which any Indemnitee may become subject (x) under the 1933 Act
or otherwise, in connection with the offer and sale of the Units, and (y) as a result of the breach of any representation,
warranty or covenant made by the Company herein, regardless of whether such losses, claims, damages, liabilities or expenses shall
result from any claim of any Indemnitee or any third party; and (ii) reimburse each Indemnitee for any legal or other expenses
reasonably incurred in connection with investigating or defending against any such loss, claim, action, damage or liability; provided,
however, that the Company will not be liable in any such case to the extent that any such claim, damage or liability results
from (A) an untrue statement or alleged untrue statement of a material fact made in the Memorandum, or an omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, made
solely in reliance upon and in conformity with written information furnished to the Company by the Placement Agent specifically
for use in the preparation thereof, or (B) any violations by the Placement Agent of the 1933 Act or state securities laws that
does not result from a violation thereof by the Company or any of its affiliates, or (C) the gross negligence or willful misconduct
of the Placement Agent to the extent and only to the extent if found in a final judgment by a court
of competent jurisdiction. In addition to the foregoing
agreement to indemnify and reimburse, the Company will indemnify and hold harmless each Indemnitee from and against any and all
losses, claims, damages, liabilities or expenses whatsoever (or actions or proceedings or investigations in respect thereof), joint
or several (which shall for all purposes of this Agreement, include, but not be limited to, all costs of defense and investigation
and all reasonable attorneys’ fees, including appeals) to which any Indemnitee may become subject insofar as such costs,
expenses, losses, claims, damages or liabilities arise out of or are based upon the claim of any person or entity that he or it
is entitled to broker’s or finder’s fees from any Indemnitee in connection with the Offering.

 

    	18

    	 

    
 

 

(b) The Placement
Agent will indemnify and hold harmless the Company, its officers, directors, employees and each person, if any, who controls the
Company within the meaning of the 1933 Act against, and pay or reimburse any such person for, any and all losses, claims, damages
or liabilities or expenses whatsoever (or actions, proceedings or investigations in respect thereof) to which the Company or any
such person may become subject under the 1933 Act or otherwise, whether such losses, claims, damages, liabilities or expenses shall
result from any claim of the Company, any of its officers, directors, employees, agents, or any person who controls the Company
within the meaning of the 1933 Act or any third party, but only to the extent that such losses, claims, damages or liabilities
are based upon any untrue statement or alleged untrue statement of any material fact contained in the Memorandum made in reliance
upon and in conformity with information contained in the Memorandum relating to the Placement Agent, or an omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading,
in either case, if made or omitted in reliance upon and in conformity with written information furnished to the Company by the
Placement Agent, specifically for use in the preparation thereof. The Placement Agent will reimburse the Company or any such person
for any legal or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim,
damage, liability or action, proceeding or investigation to which such indemnity obligation applies. Notwithstanding the foregoing,
in no event (except in the event of gross negligence or willful misconduct by the Placement Agent to
the extent and only to the extent if found in a final judgment by a court of competent jurisdiction) shall the Placement
Agent’s indemnification obligation hereunder exceed the amount of the Agent’s Fee actually received by it.

 

    	19

    	 

    
 

(c) Promptly after
receipt by an indemnified party under this Section 8 of notice of the commencement of any action, claim, proceeding or investigation
(the “Action”), such indemnified party, if a claim in respect thereof is to be made against the indemnifying
party under this Section 8, will notify the indemnifying party of the commencement thereof, but the omission to so notify the indemnifying
party will not relieve it from any liability which it may have to any indemnified party under this Section 8 unless the indemnifying
party has been substantially prejudiced by such omission. The indemnifying party will be entitled to participate in, and, to the
extent that it may wish, jointly with any other indemnifying party, to assume the defense thereof subject to the provisions herein
stated, with counsel reasonably satisfactory to such indemnified party. The indemnified party will have the right to employ separate
counsel in any such Action and to participate in the defense thereof, but the fees and expenses of such counsel will not be at
the expense of the indemnifying party if the indemnifying party has assumed the defense of the Action with counsel reasonably satisfactory
to the indemnified party; provided, however, that if the indemnified party shall be requested by the indemnifying party
to participate in the defense thereof or shall have concluded in good faith and specifically notified the indemnifying party either
that there may be specific defenses available to it which are different from or additional to those available to the indemnifying
party or that such Action involves or could have a Material Adverse Effect upon it with respect to matters beyond the scope of
the indemnity agreements contained in this Agreement, then the counsel representing it, to the extent made necessary by such defenses,
shall have the right to direct such defenses of such Action on its behalf and in such case the reasonable fees and expenses of
such counsel in connection with any such participation or defenses shall be paid by the indemnifying party. No settlement of any
Action against an indemnified party will be made without the consent of the indemnifying party and the indemnified party, which
consent shall not be unreasonably withheld or delayed in light of all factors of importance to such party and no indemnifying party
shall be liable to indemnify any person for any settlement of any such claim effected without such indemnifying party’s consent.

 

9. Contribution.
To provide for just and equitable contribution, if (i) an indemnified party makes a claim for indemnification pursuant to Section
8 hereof and it is finally determined, by a judgment, order or decree not subject to further appeal that such claims for indemnification
may not be enforced, even though this Agreement expressly provides for indemnification in such case; or (ii) any indemnified or
indemnifying party seeks contribution under the 1933 Act, the 1934 Act or otherwise, then each indemnifying party shall contribute
to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative
benefits but also the relative fault of the Company on the one hand and the Placement Agent on the other in connection with the
statements or omissions which resulted in such losses, claims, damages, liabilities or expenses (or actions in respect thereof),
as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Placement
Agent on the other shall be deemed to be in the same proportion as the total net proceeds from the Offering (before deducting expenses)
received by the Company bear to the total commissions and fees actually received by the Placement Agent (except in the case of
gross negligence or willful misconduct by the Placement Agent to the extent and only to the extent if
found in a final judgment by a court of competent jurisdiction). The relative fault, in the case of an untrue statement,
alleged untrue statement, omission or alleged omission will be determined by, among other things, whether such statement, alleged
statement, omission or alleged omission relates to information supplied by the Company or by the Placement Agent, and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such statement, alleged statement, omission
or alleged omission. The Company and the Placement Agent agree that it would be unjust and inequitable if the respective obligations
of the Company and the Placement Agent for contribution were determined by pro rata allocation of the aggregate losses,
liabilities, claims, damages and expenses or by any other method or allocation that does not reflect the equitable considerations
referred to in this Section 9. No person guilty of a fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933
Act) will be entitled to contribution from any person who is not guilty of such fraudulent misrepresentation. For purposes of this
Section 9, each person, if any, who controls the Placement Agent within the meaning of the 1933 Act will have the same rights to
contribution as the Placement Agent, and each person, if any, who controls the Company within the meaning of the 1933 Act will
have the same rights to contribution as the Company, subject in each case to the provisions of this Section 9. Anything in this
Section 9 to the contrary notwithstanding, no party will be liable for contribution with respect to the settlement of any claim
or action effected without its written consent. This Section 9 is intended to supersede, to the extent permitted by law, any right
to contribution under the 1933 Act, the 1934 Act or otherwise available.

 

    	20

    	 

    
 

 

10. Termination.

 

(a) The Offering
may be terminated by the Placement Agent at any time prior to the expiration of the Offering Period by notifying the Company in
the event that: (i) any of the representations, warranties or covenants of the Company contained herein, in the Memorandum or in
any other Transaction Document shall prove to have been false or misleading in any material respect when actually made; (ii) the
Company shall have failed to perform any of its material obligations hereunder or under any other Transaction Document after the
Company is given a reasonable time to cure the default and perform; (iii) there shall occur any event, within the control of the
Company, that could materially and adversely affect the transactions contemplated by this Agreement or the other Transaction Documents
or the ability of the Company to perform hereunder or thereunder; or (iv) the Placement Agent determines in good faith and it is
agreed by the Company that it is reasonably unlikely that any of the conditions to the First Closing set forth herein will or can
be satisfied. In the event of any such termination by the Placement Agent pursuant to clauses (i), (ii) or (iii) of this Section
10(a), the Placement Agent shall be entitled to receive from the Company, within five (5) business days of the Termination Date,
in addition to other rights and remedies it may have hereunder, at law or otherwise, an amount equal to the sum of: (A) any and
all Agent’s Fee and Agent Expense Allowance, which would have been earned through the Termination Date based on amounts in
the Escrow Account (provided that in the event no funds are in the Escrow Account at such time, the Placement Agent shall be entitled
to reimbursement of all of its actual out of pocket expenses incurred up to such date) and shall retain any Agent’s Fee and
Agent Expense Allowance for closings, if any, previously consummated (collectively, the “Termination Amount”),
(B) all amounts, if any, which may become payable to the Placement Agent in respect of (X) Post-Closing Investors pursuant to Section
4(g) hereof and within the time frame set forth in Section 4(g) hereof and (Y) Finder’s Fee pursuant to Section 4(h) and
within the time frame set forth in Section 4(h) hereof, and (C) other amounts as may be due under any indemnity or contribution
obligation provided herein or any other Transaction Document, at law or otherwise. In the event of any such termination by the
Placement Agent pursuant to clauses (iv) of this Section 10(a), the Placement Agent shall be entitled to receive from the Company,
within five (5) business days of the Termination Date, in addition to other rights and remedies it may have hereunder, at law or
otherwise, reimbursement of unpaid costs and expenses incurred by the Placement Agent in connection with the Offering which amount
shall not exceed $25,000.

 

    	21

    	 

    
 

 

(b) The Offering
may be terminated by the Company at any time prior to the expiration of the Offering Period in the event that the Placement Agent
shall have failed to perform any of its material obligations hereunder (excluding the Placement Agent’s failure to raise
the Minimum Amount hereunder). In the event of any such termination by the Company, the Placement Agent shall not be entitled to
any amounts whatsoever except (i) to retain any Agent’s Compensation and Agent Expense Allowance earned through the Termination
Date for Closings that have been consummated prior to such termination, (ii) reimbursement by
the Company of unpaid costs and expenses incurred by the Placement Agent in connection with the Offering which amount shall not
exceed $25,000 and (iii) as may be due under any indemnity or contribution obligation provided herein or any other Transaction
Document, at law or otherwise.

 

(c) In the event
the Company unilaterally decides for any reason (other than because of the failure of the Placement Agent to perform any of its
material obligations under this Agreement) to terminate the Offering at any time prior to the First Closing (the “Company
Termination”), the Placement Agent shall be entitled to receive from the Company the Termination Amount. In addition,
if within twelve (12) months after the Company Termination, the Company conducts a public or private offering of its securities
or enters into a letter of intent with respect to the foregoing, then upon the closing of any such transaction, the Placement Agent
shall be entitled to receive from the Company an amount equal to the sum of: (x) the Agent’s Fee calculated as if there had
been a closing on the Maximum Amount and (y) the Agent Expenses calculated as if there had been a closing on the Maximum Amount
(the “Company Termination Amount”); provided, however, that if the Company has previously paid to the
Placement Agent the Termination Amount, the Placement Agent shall be entitled to receive only such portion of the Company Termination
Amount that is in excess of the Termination Amount previously paid to the Placement Agent.

 

(d) Before any
termination by the Placement Agent under Section 10(a) or by the Company under Sections 10(b) or 10(c) shall become effective,
the terminating party shall give written notice to the other party of its intention to terminate the Offering (the “Termination
Notice”). The Termination Notice shall specify the grounds for the proposed termination. If the specified grounds for
termination, or their resulting adverse effect on the transactions contemplated hereby, are curable, then the other party shall
have ten (10) days from the Termination Notice within which to remove such grounds or to eliminate all of their material adverse
effects on the transactions contemplated hereby; otherwise, the Offering shall terminate.

 

(e) Upon any termination
pursuant to this Section 10, the Placement Agent and the Company shall instruct the Escrow Agent to cause all monies received with
respect to the subscriptions for Units not accepted by the Company to be promptly returned to such subscribers without interest,
penalty, expense or deduction. The Company shall be responsible for any outstanding fees owed to the Escrow Agent.

 

    	22

    	 

    
 

 

11. Survival.

 

(a) The obligations
of the parties to pay any costs and expenses hereunder and to provide indemnification and contribution as provided herein shall
survive any termination hereunder.

 

(b) The respective
indemnities, covenants, agreements, representations, warranties and other statements of the Company and the Placement Agent set
forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any investigation made by or on
behalf of, and regardless of any access to information by, the Company or the Placement Agent, or any of their officers or directors
or any controlling person thereof, and will survive the sale of the Units or any termination of the Offering hereunder (it being
understood and agreed that the representations and warranties of the Company and the Placement Agent set forth in, respectively,
Sections 2 and 3 hereof, shall only survive for a period of two (2) years from the earlier to occur of (i) the termination of this
Agreement for any reason or (ii) the Final Closing.

 

12. Notices.
All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given
or made as of the date delivered personally, or the date mailed if mailed by registered or certified mail (postage prepaid, return
receipt requested) to the parties at the following addresses (or at such other address for a party as shall be specified by like
changes of address which shall be effective upon receipt) or sent by facsimile transmission, with confirmation received, if sent
to the Placement Agent, will be mailed, delivered or telefaxed and confirmed to: Spencer Trask Ventures, Inc., 1700 East Putnam
Avenue, Old Greenwich, Connecticut 06870, Attention: John Heidenreich, President, fax number: (212) 829-4405, with a copy (which
shall not constitute notice) to: Littman Krooks LLP, 655 Third Avenue, 20th Floor, New York, New York 10017, Attention:
Steven D. Uslaner, Esq., fax number: (212) 490-2990, and if sent to the Company, to: LabStyle Innovations Corp., 350 Fifth Avenue,
59th Floor, New York, NY 10018, Attention: Chief Executive Officer, fax number: (646) 349-3180, with a copy (which shall
not constitute notice) to: Ellenoff Grossman & Schole LLP, 150 East 42nd Street, 11th
Floor, New York, NY 10017, Attention: Lawrence A. Rosenbloom, Esq., fax number: (646) 895-7204.

 

13. Arbitration,
Choice of Law; Costs. This Agreement shall be deemed to have been made and delivered
in New York City and shall be governed as to validity, interpretation, construction, affect and in all other respects by the internal
laws of the State of New York. THE PARTIES AGREE THAT ANY DISPUTE, CLAIM OR
CONTROVERSY DIRECTLY OR INDIRECTLY RELATING TO OR ARISING OUT OF THIS AGREEMENT, THE TERMINATION OR VALIDITY HEREOF, ANY ALLEGED
BREACH OF THIS AGREEMENT OR THE ENGAGEMENT CONTEMPLATED HEREBY (ANY OF THE FOREGOING, A “CLAIM”) SHALL BE SUBMITTED
TO THE JUDICIAL ARBITRATION AND MEDIATION SERVICES, INC (“JAMS”), OR ITS SUCCESSOR, IN NEW YORK, FOR FINAL AND BINDING
ARBITRATION IN FRONT OF A PANEL OF THREE ARBITRATORS WITH JAMS IN NEW YORK, NEW YORK UNDER THE JAMS COMPREHENSIVE ARBITRATION RULES
AND PROCEDURES (WITH EACH OF THE SELLING AGENT AND THE COMPANY CHOOSING ONE ARBITRATOR, AND THE CHOSEN ARBITRATORS CHOOSING THE
THIRD ARBITRATOR).  THE ARBITRATORS SHALL, IN THEIR AWARD, ALLOCATE ALL OF THE COSTS OF THE ARBITRATION, INCLUDING THE FEES
OF THE ARBITRATORS AND THE REASONABLE ATTORNEYS’ FEES OF THE PREVAILING PARTY, AGAINST THE PARTY WHO DID NOT PREVAIL. 
THE AWARD IN THE ARBITRATION SHALL BE FINAL AND BINDING.  THE ARBITRATION SHALL BE GOVERNED BY THE FEDERAL ARBITRATION ACT,
9 U.S.C. SEC. 1-16, AND THE JUDGMENT UPON THE AWARD RENDERED BY THE ARBITRATORS MAY BE ENTERED BY ANY COURT HAVING JURISDICTION
THEREOF.  THE COMPANY AND THE PLACEMENT AGENT AGREE AND CONSENT TO PERSONAL JURISDICTION, SERVICE OF PROCESS AND VENUE IN
ANY FEDERAL OR STATE COURT WITHIN THE STATE AND COUNTY OF NEW YORK IN CONNECTION WITH ANY ACTION BROUGHT TO ENFORCE AN AWARD IN
ARBITRATION.

 

    	23

    	 

    
 

 

14. Modification;
Performance; Waiver. No provision of this Agreement may be changed or terminated except by a writing signed by the party or
parties to be charged therewith. Unless expressly so provided, no party to this Agreement will be liable for the performance of
any other party’s obligations hereunder. Any party hereto may waive compliance by the other with any of the terms, provisions
and conditions set forth herein; provided, however, that any such waiver shall be in writing specifically setting forth
those provisions waived thereby. No such waiver shall be deemed to constitute or imply waiver of any other term, provision or condition
of this Agreement.

 

15. Entire Agreement.
This Agreement, together with any other agreement referred to herein, supersedes all prior agreements between the parties with
respect to the Units to be offered and sold hereunder and the subject matter hereof.

 

16. Execution
in Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, and all of
which taken together shall constitute one and the same agreement (and all signatures need not appear on anyone counterpart). In
the event that any signature is delivered by facsimile transmission or by e-mail delivery of a data file, such signature shall
create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force
and effect as if such facsimile or data file signature page were an original thereof. This Agreement shall become effective when
one or more counterparts has been signed and delivered by each of the parties hereto.

 

17. Severability.
If any provision of this Agreement is held to be illegal, invalid or unenforceable under any present or future laws, such provision
shall be fully severable. This Agreement shall be construed and enforced as if such illegal, invalid or unenforceable provision
had never comprised a part of this Agreement, and the remaining provisions of this Agreement shall remain in full force and effect
and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from this Agreement. Furthermore,
in lieu of each such illegal, invalid or unenforceable provision there shall be deemed added automatically as a part of this Agreement
a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible to cause such provision
to be legal, valid and enforceable.

 

    	24

    	 

    
 

 

18. Headings.
The captions and headings used in this Agreement are for convenience only and do not in any way affect, limit, amplify or modify
the terms and provisions of this Agreement.

 

19. Assignment.
The Company may not assign its rights or obligations hereunder without the prior written consent of the Placement Agent. Except
as provided in Section 4 hereof with regard to selected dealers, the Placement Agent may not assign its rights or obligations hereunder
without the prior written consent of the Company.

 

 

[SIGNATURE PAGE FOLLOWS]

 

    	25

    	 

    
 

 

If the foregoing is
in accordance with your understanding of our agreement, kindly sign and return this Agreement, whereupon it will become a binding
agreement between the Company and the Placement Agent in accordance with its terms.

 

Very truly yours,

 

LABSTYLE INNOVATIONS CORP.

 

 

 

By: /s/ Oren Fuerst

Name: Oren Fuerst

Title: Chief Executive Officer

 

 

Accepted and agreed to as of the date

first written above:

 

SPENCER TRASK VENTURES, INC.

 

 

 

By: /s/ John Heidenreich

Name: John Heidenreich

Title: President

 

 

[Signature Page to Placement Agency Agreement,
dated September 8, 2011]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}]]